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Abstract
COMPUTATIONAL ANALYSIS AND PREDICTION OF INTRINSIC DISORDER AND
INTRINSIC DISORDER FUNCTIONS IN PROTEINS
By Akila Imesha Katuwawala
A dissertation submitted in partial fulfillment of the requirements for the degree of Engineering,
Doctor of Philosophy with a concentration in Computer Science at Virginia Commonwealth
University.
Virginia Commonwealth University, 2021
Director: Lukasz Kurgan,
Professor, Department of Computer Science
Proteins, as a fundamental class of biomolecules, have been studied from various perspectives
over the past two centuries. The traditional notion is that proteins require fixed and stable threedimensional structures to carry out biological functions. However, there is mounting evidence
regarding a “special” class of proteins, named intrinsically disordered proteins, which do not have
fixed three-dimensional structures though they perform a number of important biological
functions. Computational approaches have been a vital component to study these intrinsically
disordered proteins over the past few decades. Prediction of the intrinsic disorder and functions
of intrinsic disorder from protein sequences is one such important computational approach that
has recently gained attention, particularly in the advent of the development of modern machine
learning techniques.
This dissertation runs along two basic themes, namely, prediction of the intrinsic disorder and
prediction of the intrinsic disorder functions. The work related to the prediction of intrinsic
disorder covers a novel approach to evaluate the predictive performance of the current
xvii | P a g e

computational disorder predictors. This approach evaluates the intrinsic disorder predictors at
the individual protein level compared to the traditional studies that evaluate them over large
protein datasets. We address several interesting aspects concerning the differences in the
protein-level vs. dataset-level predictive quality, complementarity and predictive performance of
the current predictors. Based on the findings from this assessment we have conceptualized,
developed, tested and deployed an innovative platform called DISOselect that recommends the
most suitable computational disorder predictors for a given protein, with an underlying goal to
maximize the predictive performance. DISOselect provides advice on whether a given disorder
predictor would provide an accurate prediction for a given protein of user’s interest, and
recommends the most suitable disorder predictor together with an estimate of its expected
predictive quality. The second theme, prediction of the intrinsic disorder functions, includes firstof-its-kind evaluation of the current computational disorder predictors on two functional subclasses of the intrinsically disordered proteins. This study introduces several novel evaluation
strategies to assess predictive performance of disorder prediction methods and focuses on the
evaluation for disorder functions associated with interactions with partner molecules. Results of
this analysis motivated us to conceptualize, design, test and deploy a new and accurate machine
learning-based predictor of the disordered lipid-binding residues, DisoLipPred. We empirically
show that the strong predictive performance of DisoLipPred stems from several innovative
design features and that its predictions complements results produced by current disorder
predictors, disorder function predictors and predictors of transmembrane regions. We deploy
DisoLipPred as a convenient webserver and discuss its predictions on the yeast proteome.
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Chapter 1. Introduction
Proteins are the actual workhorse behind the cellular functions in all living cells and viruses.
These functions are governed by a mechanism known as the central dogma of biology where
the genetic information encoded in DNA flows to RNA and where the messenger RNAs (genes)
encode protein sequences [1]. Furthermore, the central dogma of structural biology is that one
protein sequence has one structure and that this structure determines function of this protein
sequence. Correspondingly, the conventional belief among biologists used to be that fixed and
stable three-dimensional structures of proteins are essential for their function. Contemporary
studies have revealed the existence of a large number of proteins and protein regions which
perform important biological functions without having fixed and stable three-dimensional
structures [2]. These regions without stable three-dimensional structure are generally identified
as intrinsically disordered regions (IDRs). Proteins that include of one or more IDRs are referred
to as the intrinsically disordered proteins (IDPs). The IDRs are widespread among three
kingdoms of life as well as in viruses. Topical bioinformatics studies have suggested that IDRs
are present in about 30% of proteins in Eukaryote, around 20% of proteins in Bacteria and
Archaea domains and over 20% in viral proteins [3, 4]. A wide spectrum of important biological
functions is performed by IDRs/IDPs. Interactions with biomolecules such as proteins, nucleic
acids, lipids, metals etc., acting as domain linkers and entropic chains are some of common
examples of these functions [5-7].
In general, computational tools contribute to protein studies from two basic viewpoints. First,
they provide support to analyze massive amounts of data generated by high throughput protein
sequencing platforms with the goal to reveal interesting patterns and trends. The other key
contribution is their use as predictive platforms to explore untouched territories in protein
sciences. The rate at which new protein sequences are being discovered has accelerated in recent
years with the aid of new and cheap high-throughput sequencing techniques. Yet, compared to
that rapid growth in the sequence space, we have access to only a relatively small amount of the
experimentally annotated IDPs/IDRs, all the while studies suggest that they are prevalent in living
organisms and viruses. The experimental annotations of IDPs/IDRs are deposited in public
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repositories like Disprot[8] and Protein Data Bank (PDB)[9]. Conventional experimental
techniques to annotate IDPs/IDRs are unable to keep up on par with the rate of production of
the new protein sequences. As a result of this mismatch of rates, the gap between the number
of the protein sequences and their available IDP/IDR annotations keeps widening. This is where
the computational IDP/IDR predictors come into action. At this point, around 70 IDP/IDR related
computational predictors were already published in the peer-reviewed literature [10-14].
Multiple studies show that they can accurately predict IDP/IDRs [15-18]. This work focuses on
the computational disorder and disorder function predictions and assessment of these
predictions.

1.1 Motivation
We investigate computational approaches that predict IDPs/IDRs and their related functions. We
cover two basic themes, namely, predicting disorder and predicting functions of IDPs/IDRs in
protein sequences. From the prediction of disorder perspective, to date the assessments of the
predictive performance of disorder predictors have been carried out using large datasets without
considering the performance at the individual protein level [14, 16]. We consider an interesting
and new angle to investigate whether the datasets level performance is comparable to the
performance at the protein level. Moreover, we note the number of the available computational
methods that predict disorder in proteins. This large number of methods could confuse users,
particularly those unfamiliar with this field. A proper guidance how to select suitable predictor
would be invaluable to ensure that users can achieve highest predictive quality for a given protein
of their interest. Considering the second theme related to predicting functions of IDPs/IDRs, to
date there have been no study that investigates how well the current computational disorder
predictors perform for specific functional subclasses of disordered proteins, particularly the
commonly occurring IDRs that interact with proteins and nucleic acids. Such study would provide
a valuable perspective for the development of predictors of specific functions of disorder.
Moreover, some of functions in IDPs/IDRs do not have any methods that could be used to predict
them in protein sequences [4, 18, 19]. The lipid binding is one such function of disorder that is
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yet to be addressed with a predictive method. Correspondingly, we focus on addressing the
following four issues:
1. How the predictive performance of disorder predictors at protein level compares with the
current results that rely on the dataset level performance?
2. Is it possible to recommend predictors that perform well for specific protein sequences?
3. What is the predictive performance of the current disorder predictors for disordered
proteins with protein binding regions and disordered nucleic acid binding regions?
4. Is it possible to accurately predict disordered lipid-binding residues from protein
sequences?

1.2 Objectives and Proposed Contributions
This dissertation includes four main objectives which are organized in a sequential manner,
where one objective flows into and motivates the next one. With the overarching goal to explore
novel approaches for disorder and disorder function prediction we start with an exploratory
analysis to identify relatively unexplored niche areas related to these predictions. This analysis
motivates and informs us in the development of novel computational approaches to address
specific issues in these niche areas.
The four main objectives are as follows.
Objective 1: Elucidation and comparative analysis of protein-level predictive performance for
current disorder predictors.
We empirically investigate the disparity between protein-level and dataset-level predictive
performance for the widely used disorder predictors. Since proteins are very diverse in their
sequences and functions, we expect a considerable variation of the predictive performance
across individual proteins, which is contrast to more “stable” and predictable benchmark dataset
level performance.
Objective 2: Development of a novel protein-level predictor recommendation system to
improve predictive performance of disorder predictions.
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Findings from objective 1 show that certain methods perform particularly well (or rather poorly)
for certain proteins. This predictive performance depends on the physiochemical properties of
the individual proteins. We use this observation to conceptualize, design, build and test a novel
recommendation engine that predicts the better performing methods for given individual
proteins using their unique sequence-derived physiochemical properties.
Objective 3: Assessment and comparative analysis of the predictive performance of disorder
predictions for specific functional types of disordered proteins.
We identify two common functional types of disordered proteins based on their binding partners:
those that bind to proteins and nucleic acids. We assessed the predictive performance of widely
used disorder predictors for above two functional subclasses of disordered proteins to
investigate potential strengths and weaknesses of the current methods. This analysis aims to
identify the functional subclasses of disordered proteins that may need further improvements in
the quality of the disorder predictions. Motivated by the results from the objective 1, we perform
this analysis at both dataset and protein levels.
Objective 4: Accurate prediction of the disordered lipid-binding residues from protein
sequences.
Objective 3 reveals that predictions of disordered proteins that interact with proteins and nucleic
acids are reasonably accurate. However, we note lack of tools that can predict interactions with
other partner molecules, such as lipids. Consequently, we conceptualize, design, develop and
comprehensively test a new computational tool that provides accurate prediction of the
currently unexplored disordered lipid binding regions.

1.3 Organization of the dissertation
This section provides a brief outline to the flow of the upcoming chapters starting from chapter
two.
Chapter Two provides background concerning the concepts and methods that are used in this
research. As this is a multidisciplinary research area, the basic concepts cover two different
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domains: Biological Sciences and Computer Science. Section one of the chapter two introduces
the background on proteins and disorder in proteins. Furthermore, it describes the functional
importance of intrinsically disordered proteins from a biological and biochemical perspective.
The second part of this chapter introduces existing computational approaches to predict disorder
and disorder functions in proteins.
Chapter Three and the following chapters are organized in a sequential manner to reflect the
flow of the four objectives. In chapter three, we analyze the predictive performance of a
comprehensive set of disorder predictors at the individual protein level. In this chapter, we
contrast the protein level predictive performance of disorder predictors with their dataset level
performance. Finally, we demonstrate the differences between dataset level and protein level
performances through a detailed analysis and a case study.
Chapter Four is motivated by the findings from chapter three. Based on the differences in the
predictive performances of disorder predictors at the individual protein level, we conceptualize,
design and empirically test a novel system that recommends the most suitable/accurate disorder
predictor(s) for individual proteins. This method aims to outperform the predictive quality
offered by current representative set of disorder predictors. Moreover, it provides an innovative
ability to estimate predictive performance of a given disorder predictors for a specific protein
before the prediction is calculated.
Chapter Five analyzes a set of representative disorder predictors with respect to their predictive
performance on two large functional subclasses of disordered proteins. We categorize
disordered proteins based on their associated functions defined in the DisProt database. Next,
we use the functionally annotated proteins from this database to perform comparative empirical
assessment of the disorder predictors. We perform this assessment on multiple versions of the
benchmark dataset after reducing the sequence similarity to the training datasets of evaluating
predictors as well as after experimentally validating the unannotated regions in the disordered
proteins. The motivation behind this analysis is to identify the areas that may require further
improvements when it comes to the accuracy of the disorder predictions.
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Chapter Six introduces a new methodology that predicts disordered lipid-binding residues. We
review the current relevant methods to identify the fact that this important function of disorder
lacks computational predictors. The current tools predict several other disorder functions and
related transmembrane regions. We conceptualize, design and test an innovative deep recurrent
neural network model that accurately identifies disordered lipid binding regions in proteins. We
comprehensively validate predictive performance of this model and compare it to current related
tools, with the goal to demonstrate that it provides high-quality and complementary results.
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Chapter 2. Background and Related Work
2.1 Introduction to proteins, intrinsic disorder and its functions
Proteins are found in all living systems including simple organisms, such as bacteria/virus, as well
as complex mammals, like humans. The word protein has originated from a Greek source
proteos, which means “of prime importance” or “of first rank” [20]. As the name suggests, these
are very (most) important biomolecules. The functions that proteins perform span across a wide
range of biochemical and biological activities. Some of the examples are enzymes that catalyze
biochemical reactions, hemoglobin for transportation, myoglobin for storage, and collagen for
structure. The basic building block of proteins is called amino acid (AA). Several AAs bind to each
other by peptide bonds to make polypeptide chains. One or more of these polypeptide chains
folds in three-dimensional space to make a protein. The three-dimensional folding of polypeptide
chains plays a crucial role to define the function for many of the proteins. The spatial
conformation, commonly known as structure of the protein, is hierarchically organized into four
levels. The primary structure is the liner sequential chains of amino acids, also referred as
polypeptide chains. The secondary structure is the organization of the polypeptide chains into
local and regular structural blocks that include α-helices and β-strands. The tertiary structure is
defined by the 3D folding of those secondary structures. The highest level, the quaternary
structure, involves spatial arrangement of multiple folded polypeptide chains.
2.1.1

Intrinsic disorder in proteins

The long-held convention is that proteins function comes as a linear flow from sequence to
structure to the function. This notion emphasizes the fact that amino acid sequence governs the
protein three-dimensional structure that directly determines the functions [2]. The threedimensional structures of proteins are generally revealed through experimental techniques, like
X-Ray crystallography, Nuclear Magnetic Resonance (NMR) and electron microscopy. The
recently growing evidence reveals presence of a special class of proteins that have fundamentally
challenged the classical paradigm that rigid three-dimensional structure is required for proteins
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to function. These proteins exist as dynamic conformational ensembles without a fixed/rigid
three-dimensional structure. They may lack the defined structure in entirety or in a specific
region and correspondingly they are known as intrinsically disordered proteins (IDPs) and
intrinsically disordered regions (IDRs) [21-23]. The functional studies of IDPs/IDRs are done
directly from the AA sequence, typically without attempting to reveal their (ensembles of)
structure. IDPs/IDRs are estimated to be abundant in all living systems and viruses. Recent
studies suggest that eukaryotes, bacteria and archaea have on average 19%, 6% and 4% of the
disordered amino acids, respectively[4]. Furthermore, eukaryotic proteomes consist of 30% to
50% of proteins that have long IDRs (≥ 30 consecutive AAs) [3, 24]. The fully disordered proteins
account for 6% to 17% of the proteins across various genomes[25]. The experimental annotations
of IDPs/IDRs are deposited in several databases. Disprot [8] and IDEAL[26] include experimentally
annotated information regarding function of IDPs/IDRs. Furthermore, while the Protein Data
Bank (PDB) is primarily used as a repository of protein structures [9], is also provides information
about IDPs/IDRs that “hide” in the regions with missing coordinates in the crystal structures and
can be directly observed as extremely flexible residues in the NMR structures [27]. Even though
these databases provide valuable information regarding IDPs/IDRs, they represent only a rather
small number of proteins. The latest version of Disprot has 1 600 proteins and 3 500 IDRs,
compared to the number of currently sequences proteins that has reached 214 million (as of April
2021).
Figure 1 illustrates the intrinsic disorder using the NMR structure of human Bcl-2-like protein 1
(PDB ID: 2ME8)[28]. This protein is an inhibitor for the programmed cell death (DisProt ID:
DP00298)[29]. The three-dimensional structure of this protein was resolved by X-ray
crystallography and NMR techniques. An intrinsically disordered region from 28th to 80th residue
was identified by missing electron density of X-ray crystallography data[30]. Furthermore,
experimental evidence shows that this intrinsically disordered regions acts as a flexible linker[30].
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Figure 1: The PyMOL visualization of NMR structure of human Bcl-2-like protein 1 (PDB ID: 2ME8). All 20
different models are overlapped, and single color denotes a single model.

The PyMOL[31] cartoon visualization of the above proteins shows 20 different superimposed
structures/conformation to illustrate the structural ensembles that make up disordered regions;
each color denotes a single structure. The dense grey part in the middle corresponds to an
ordered/structured region where all conformations converge into one fixed structure. The
surrounding sparely distributed multi-color sections corresponding to the disordered region.
2.1.2

Functional aspect of intrinsically disordered proteins

The wide range of functions that performs by IDPs/IDRs is broadly classified into two categories:
by molecular level functions and by the interacting molecular partners [5, 22, 32]. This
classification schema is followed by the DisProt database, the primary and largest source of the
functional annotation of IDP/IDR [33, 34]. The molecular functions of the IDRs are further divided
into seven classes: entropic chains, display sites, chaperons, effectors, assemblers, scavengers,
and biological condensation[22]. Entropic chains are permanently unstructured to perform the
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functions that needs a great degree of flexibility. IDRs present in the titin protein provides a good
example for entropic chains[35]. Display sites act as facilitators for the post-translational
modifications and they are located inside IDRs[36]. This localization facilitates downstream
reactions that occur after catalytic site modifying enzyme approaches the effector protein[37].
The functional category of IDRs that acts as chaperons facilitates the folding of RNA molecules
and other proteins into their functional conformations[38]. More than 33% of RNA chaperons
and over 50% of protein chaperons are reported to be disordered[39]. The effectors show a
functional shift upon binding to another molecule and transform from disorder to order state –
this process is known as coupled folding and binding[40, 41]. The cell cycle regulatory proteins
named p21 and p27 in the family of the cyclin dependent kinase and p53, which has multiple
binding partners, are excellent examples of well-studied effectors. Assemblers serve as hub
proteins that bring large number of proteins together to form large complexes. They act as either
scaffolds or structural mortars to stabilize large molecular complexes [42, 43]. Examples of the
assemblers that perform stabilizing function are the hub proteins which collects β-catenin, casein
kinase Iα, and glycogen synthetase kinase 3β[44]. The scavengers digest and discard the debris
of small ligands. Adrenaline and ATP scavenger by Chromogranin A are good examples for
scavenging activity[45].
The other functional classification scheme of IDRs is according to their binding partners. This
classification includes seven well-known categories of molecules that binds to IDR, namely
proteins, DNAs, RNAs, lipids, metals, inorganic salt and small molecules. This supplements the
information associated with some of the molecular function categories, such as effectors,
chaperons, assemblers and scavengers.
The current version of 8.0 of the DisProt provides information for 2494 experimentally annotated
unambiguous disorder regions. Table 1 shows the seven molecular level function level categories
and their sub categories with the corresponding counts of proteins and functionally annotated
disordered regions. The category with highest number of annotations is the molecular
recognition assemblers, with 570 regions in 252 proteins. The other two highly annotated
categories are the entropic chains (particularly the sub category of flexible linkers that has 175
regions) and molecular recognition effectors, which are covered by 448 and 488 regions,
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respectively. Apart from above, the other four categories have relatively low numbers of
annotations: recognition display sites with 270 regions, chaperones with 74 regions, scavengers
with 54 regions, and biological condensation with 58 disordered regions in 40 proteins.
Table 1: Number of the molecular function annotations for the functionally annotated IDRs in the DisProt
database. Annotations tagged as ambiguous have been excluded.
Functional annotations
Molecular functions
Molecular function subcategories
Molecular Recognition:
Assembler
Assembler
Localization (targeting)
Localization (tethering)
Total
Entropic Chain
Flexible linker/spacer
Entropic bristle
Entropic spring
Self-transport through channel
Structural mortar
Total
Molecular Recognition:
Inhibitor
Effector
Activator
DNA bending
Disassembler
DNA unwinding
Total
Molecular Recognition:
Space filling
Chaperone
Entropic exclusion
Total
Molecular Recognition:
Phosphorylation
Display Site
Glycosylation
Fatty acylation
Acetylation
Ubiquitination
Limited proteolysis
ADP-ribosylation
Methylation
Total
Molecular Recognition:
Metal binding/metal sponge
Scavenger
Neutralization of toxic molecules
Water storage
Total
Biological Condensation Liquid-liquid phase separation
Amyloid
Prion
Total
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Number of annotated
IDRs
100
20
38
570
175
12
3
4
1
448
94
52
4
6
1
488
8
6
74
76
10
6
14
2
8
1
9
270
2
4
2
54
12
1
16
58

Number of
annotated proteins
51
11
22
252
117
6
2
2
1
283
59
22
3
1
1
237
2
3
33
53
5
3
10
1
4
1
7
169
1
3
1
38
12
1
7
40

Table 2 provides the annotation counts in terms of the binding partner-defined functions. The
highest number of binding partner annotations are for the protein binding, with 1126 IDRs in 598
proteins. The binding partner annotations for other partners are lower and account for 143
regions for DNA binding, 71 regions for metal binding, 63 regions for RNA binding, 45 regions for
lipid binding, 43 regions for small molecules, and just 3 regions for inorganic salt binding.
Table 2: Number of molecular partner annotations for the functionally annotated IDRs in the DisProt
database.
Molecular Partner
Protein
DNA
Metal
RNA
Small molecule
Lipid
Inorganic Salt

Number of annotated
IDRs
1126
143
71
63
43
45
3

Number of annotated
proteins
598
88
43
50
35
30
3

2.2 Residue level protein structure and function prediction in disorder proteins
2.2.1

Computational prediction of intrinsic disorder in proteins

The interest in the annotation of intrinsic disorder proteins and ever growing gap between the
available experimental annotations for disorder and the exponential growth in protein sequences
motivates the development computational methods that predict disorder in protein sequences.
Figure 2 illustrates disorder and disorder function predictions. It shows results produced by three
popular disorder predictors, IUPred-Long, IUPred-Short and SPOT disorder, for the human Bcl-2like protein 1, which we introduced in section 2.1.1. Moreover, the disorder function predictor
DFLpred was deployed to predict disordered flexible linker regions. Using the PyMOL’s
visualization of three-dimensional structure, the red color denotes ordered regions and blue
color corresponds to a disordered region. The visualization of the predictions are generated using
our recently released DEPICTER (Disorder Prediction Center) server [46], a new platform which
provides simultaneous predictions of disorder and disorder functions. The results for each
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predictor include numerical propensity scores, which quantify likelihood that a given amino acids
is disordered (the top plot), and binary predictions, which categorizes each amino acid as either
disordered or structured (presence of the horizontal bar corresponds to the disorder prediction).

A

B

1

27

80

233

GHS….GYSWSQSDVEE…………….SSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDL……….………………………………...…KGQER

Disorder and Disorder
Function Predictors

Figure 2: Panel A is three-dimensional structure of the human Bcl-2-like protein 1. The red and blue
regions denote native (experimentally annotated) ordered and disordered regions, respectively. Panel B
visualizes disorder and disorder function prediction from IUPred-Long, IUPred-Short, SPOT Disorder and
DFLpred. The top horizontal bar gives the actual/native disorder and order annotations while the panels
below show the putative propensities and the corresponding binary predictions (gray and pink horizontal
bars) generated by the four predictors. The presence of a bar denotes presence of putative disorder or
specific disorder function in the corresponding region.
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The computational prediction of disorder benefits from the fact that amino acid sequence
composition differs between the disordered and ordered regions [32, 47, 48]. Over 60 predictors
of intrinsic disorder have been developed in the past forty years [11, 13, 16, 49]. They can be
categorized in to three classes based on their underlying predictive models [11]:
1. Ab initio models.
These predictors rely on physical/analytical models that use physiochemical properties
of amino acid sequences to differentiate between disordered regions and ordered
regions. Some of the example predictors form this category would be NORSP [50] ,
GlobPlot[51] and IUPred [52].
2. Machine learning algorithms.
This category of predictors use machine-learning algorithms to produce predictive
models. These models are trained on training set to maximize fit into the known
disorder annotations and tested on an independent (low similarity to training set)
datasets of proteins. This category includes a large number of predictors with some
examples being RONN [53], DisEMBL [54], DISpro [55], DISOPRED [56], VSL2B [57],
SPINE-D [58], SPOT-Disorder [59] .
3. Meta predictors.
Meta predictors generate predictions by combining outputs from several predictors
with the intention of maximizing the predictive performance. The idea behind
developing the meta predictors is to combine complementary disorder predictions to
maximize their strong aspects (where they agree) and to minimize their weaknesses
(where they disagree) [60]. Examples meta-predictors are MetaDisorder [61], MFDp [62,
63], disCoP [60], CSpritz [64], and ESpritz [65].
Furthermore, pre-calculated disorder predictions for about a dozen of popular methods are
available in the MobiDB [66] and D2P2 [67] databases.
The predictive performance of disorder predictors have been evaluated using several benchmark
datasets. Many comparative surveys have been published [68-78]. These surveys evaluate
predictive performance of the disorder predictors on different benchmark datasets that vary in
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size from about 100 to over 20 000 proteins. One such popular assessment series was run as part
of the Critical Assessment of protein Structure Prediction (CASP) experiments between 2002
(CASP5) and 2012 (CASP10) [68, 75-79]. A popular metric to evaluate predictive performance is
the area under the curve of receiver operating cure (ROC-AUC). The ROC is a relation between
true-positive rates (TPRs) and false-positive rates (FPRs) that is computed by using many
thresholds to binarize numeric propensity scores produced by the predictors [80]. The AUC values
range from 1.0 for perfect prediction and 0.5 for random prediction. The most accurate
predictors have reached ROC-AUC of 0.89 [81] and 0.91 [79] in recent evaluations. These
numbers suggest that disorder predictors perform with acceptable levels of predictive
performance. Most of these predictors are available as standalone versions or webservers that
are free to use for the scientific community.
Table 3 summarizes nine selected, highly-cited disorder predictors. The model type column
provides information about the type of the predictive model used. Most of the disorderpredictors use machine learning-based models while only a few rely on other model types, like
biophysics-inspired scoring functions. The total number of citations column provides a
measurement of popularity for a given predictor. The annual citations give a measure that is more
adequate for side-by-side comparisons, which quantifies how frequently a predictor was cited
per year. We note that many of these methods are cited dozens of times every year, with the
most cited predictors being disEMBL, IUPred, and DISOPRED3. The website column provides the
link to the web resource where a given predictor can be downloaded or is available for online
use. We observe that all highly-cited tools are available online.
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Table 3: Summary of the nine highly-cited computational disorder predictors. The number of citations was collected from the Web of Science as
of May 2020. The methods are sorted in the ascending chronological order.

Predictor Name

Year
Ref. Model Type
Published

ESpritz

2012

disEMBL

2003

GlobPlot
JRONN
VSL2B

2003
2005
2006

IUPred

2009

DISOPRED3

2015

DeepCNF
SPOT-DISORDER

2015
2016
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[65] Bi-directional recursive neural network
Ensemble of feed-forward neural
[54]
networks
[51] Derivative based curve optimization
[53] Radial basis functional neural network
[57] Support vector machine
Scoring function based on energy
[52]
minimization
Ensemble of neural network, support
[56]
vector machine and nearest neighbor
[82] Deep convolutional neural network
[59] Deep bidirectional neural network

Annual
Number of
number of Website
Citations
citations
185
23.1
http://protein.bio.unipd.it/espritz/
840

49.4

http://dis.embl.de/

678
472
480

40.4
31.5
34.3

http://globplot.embl.de/
http://www.strubi.ox.ac.uk/RONN
http://www.dabi.temple.edu/disprot/predictor.php

335

30.5

https://iupred2a.elte.hu/

234

46.8

http://bioinf.cs.ucl.ac.uk/psipred/

26
73

5.2
18.3

https://ttic.uchicago.edu/~wangsheng/software.html
http://sparks-lab.org/server/SPOT-disorder/

2.2.2

Computational prediction of functions in intrinsically disordered proteins

In parallel to the substantial efforts towards the development of a large number of computational
disorder predictors, computational prediction of functions of IDRs has also gained a considerable
amount of attention. The development of the disorder function predictors relies on the
functional annotations from the DisProt database [33]. These annotations are used to design,
optimize, and empirically test the predictive models. Over 20 computational method that predict
various functional traits of IDR were developed, implemented and published during the past
decade [11]. These predictors predict disorder functions directly from the amino acid sequence
of input proteins. Like in the case of the disorder predictions, the underlying predictive models
use various types of machine learning algorithms and scoring functions [11]. Vast majority of
these methods use data driven machine-learning models that are trained and tested using the
available experimentally annotated functional IDRs. These methods attempt to minimize the
predictive error on designated training dataset during training phase. After training is complete,
they are tested on test datasets that include proteins that are explicitly dissimilar to the training
proteins. The test proteins usually share low sequence similarity (<30%) against training dataset
– this is to ensure that the evaluation is robust (overfitting training dataset does not lead to good
results) and that the predictions cannot be simply performed using alignment-based methods.
The 23 disorder function predictors that were published during past decade fall under two main
categories: 1) methods that predict IDRs that interact with specific binding partners; and 2)
methods that predict molecular function of IDRs. The currently available methods cover three
types of the molecular partners: proteins, DNA and RNA. The methods that predicts molecular
functions focus so far only on the flexible linkers (a type of entropic chains) and multifunctional
(moonlighting) IDRs. Table 3 summarizes the 23 existing disorder function predictors. It shows a
substantial interest towards developing new function predictors during past few years, as total
of 17 predictors were published in the last 5 years (between 2015 and 2020) compared to 6 that
were published prior to that (between 2007 and 2014).
Many of these disorder function predictors are implemented as publicly accessible web interface
and/or publicly downloadable standalone software with the source code typically available in
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freely accessible repositories. Table 3 reveals that 17 of the 23 predictors are accessible through
their websites. Among these methods, 14 are available as webservers where predictions are done
on the server side and can be obtained online. Moreover, 11 have downloadable source code
that can be installed and run locally. Furthermore, six methods are available as both webserver
and source code. We note that it is clear that the availability of these predictors is connected
with the number of citations that they have received. The median annual number of citations for
the methods without a webserver is 2 compared to 11 for the methods with webservers. The
methods that provide only source code are cited at the annual median rate of 7 and predictors
that have both code and webserver have received 9 citations per year. This speaks to the practical
value for the availability of the webservers.
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Table 4: Classification, citations and availability of the current predictors of IDR functions. The methods are categorized based on their predictive
target (molecular partner vs. molecular function) and sub-type of the target (protein, DNA and RNA for molecular partners vs. flexible linker and
moonlighting region for molecular functions). Predictors are sorted within each sub-type by the year of publication. The citations and availability
are based on information as of Feb 25, 2019. The citations were collected using Google Scholar, where the annual citations are computed as an
average number of citations per year since publication. Methods without any availability are listed as “not available” and those for which the
websites cannot be found are denoted as “no longer available”.
Predictive target
Partners

Proteins

MoRFs

SLiMs
ALL

Functions

DNAs
RNAs
Flexible linkers
Moonlighting regions
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Year

Method

Ref.

2007
2010
2012
2013
2015
2015
2015
2016
2016
2016
2017
2018
2018
2018
2018
2019
2012
2016
2009
2015
2018
2015
2015
2016
2018

alpha-MoRFpred
retro-MoRFs
MoRFpred
MFSPSSMpred
fMoRFpred
DISOPRED3
MoRFCHiBi
MoRFCHiBiLight
MoRFCHiBiWeb
Predict-MoRFs
Wang et al. 2017
MoRFpred-plus
OPAL
OPAL+
Fang et al 2018
Sharma et al. 2019
SLiMPred
PSSMpred
ANCHOR
disoRDPbind
ANCHOR2
disoRDPbind
disoRDPbind
DFLpred
DMRpred

[83, 84]
[85]
[86, 87]
[88]
[89]
[90]
[91]
[92]
[92]
[93]
[94]
[95]
[96]
[97]
[98]
[99]
[100]
[101]
[102, 103]
[104, 105]
[106]
[104, 105]
[104, 105]
[107]
[108]

Citations
Total Annual
445
27
194
32
36
206
35
22
22
6
2
8
8
0
0
0
54
0
388
44
17
44
44
17
0

37
3
28
5
12
52
12
7
7
2
2
7
6
0
0
0
8
0
39
11
10
11
11
8
0

URL
Not Available
Not Available
http://biomine.cs.vcu.edu/servers/MoRFpred/
No Longer Available
http://biomine.cs.vcu.edu/servers/fMoRFpred/
http://bioinf.cs.ucl.ac.uk/disopred
https://gsponerlab.msl.ubc.ca/software/morf_chibi/downloads/
https://gsponerlab.msl.ubc.ca/software/morf_chibi/downloads/
http://morf.chibi.ubc.ca:8080/mcw/index.xhtml
https://github.com/roneshsharma/Predict-MoRFs
Not Available
https://github.com/roneshsharma/MoRFpred-plus/wiki/MoRFpred-plus
http://www.alok-ai-lab.com/tools/opal/
http://www.alok-ai-lab.com/tools/opal_plus/
Not Available
https://github.com/roneshsharma/BMC_Models2018/wiki.
http://bioware.ucd.ie/~compass/biowareweb//Server_pages/slimpred.php
No Longer Available
http://anchor.enzim.hu
http://biomine.cs.vcu.edu/servers/DisoRDPbind/
https://iupred2a.elte.hu/
http://biomine.cs.vcu.edu/servers/DisoRDPbind/
http://biomine.cs.vcu.edu/servers/DisoRDPbind/
http://biomine.cs.vcu.edu/servers/DFLpred/
http://biomine.cs.vcu.edu/servers/DMRpred/

A vast majority of the available disorder function predictors are designed to predict proteinbinding regions in IDRs (Table 4). This can be explained by the availability of the (by far) highest
number of functionally annotated IDR in this functional category in DisProt (Table 2). The protein
binding prediction methods can be further divided into specific type of protein binding IDR that
they intended to predict. Molecular recognition features (MoRFs) are one such category that is
targeted by 16 predictors. MORFs are short protein binding regions, which usually span between
5 and 25 adjacent residues, that undergo disorder to order transition upon binding to their
protein partners and which are placed inside of longer IDRs [41, 109]. The popular MORF
predictors include alpha-MoRFpred [110, 111], which predicts MoRFs that fold into alpha helices,
MoRFpred [87], MoRFCHiBi [91], fMoRFpred [41] and DISOPRED3 [112]. The second category of
protein binding IDRs are short linear sequence motifs (SLiMs). They are short conserved motifs
usually 3 to 12 amino acids long that are involved in protein interactions [113] . The Eukaryotic
Linear Motif (ELM) resource provides a list of all currently known SLiMs that were used to design
and test these predictors. SLiMpred [100] and PSSMpred [114] are the two methods that predict
SLiMs. The remaining methods, which include ANCHOR [115], DisoRDPbind [116] and ANCHOR2A
[52], predict a generic set of protein-binding IDRs, which include the short MoRF and SLiMs as
well as longer protein-binding IDRs.
Computational approaches that predict functions other than protein binding are low in numbers.
DisoRDPbind is the only method that predicts DNA binding and RNA binding IDRs. Moreover,
DFLpred predicts flexible linkers and DMRpred predicts disordered multifunctional regions
(moonlighting regions).
The popularity of the disorder function predictors can be quantified through the number of
citations (Table 4). As of Feb 2019, The 25 predictors were cited 1651 times, with the median
number of citations at 22. Based on the annual citation numbers, the most popular predictors
are DISOPRED3 (52 citations per year), ANCHOR (39 citations per year), alpha-MoRFpred (37
citations per year), MoRFpred (28 citations per year), and fMoRFpred and MoRFCHiBi (12
citations per year). The high number of citations for DISOPRED3 could be partly due to its ability
to predict disorder in general in addition to prediction of protein binding regions in IDR.
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2.2.3

Computational modelling related to the development of disorder predictors

Prediction of IDRs and their functions in proteins can be viewed as a classification task from the
machine learning perspective. The classification task requires a fixed-size input. In this case, the
raw input is the amino acid sequence of proteins. Since these amino acid sequences are
represented as a text string of variable length, they must be converted into a fixed-length
numerical feature vector. This is where physiochemical and putative structural properties of
amino acids are used to encode sequences into the feature vectors. For example, sequence can
be converted into 20-dimensional vector of the frequencies of the 20 amino acids. Next, the input
feature vectors are processed by predictive models to produce predictions of disorder and
disorder functions. Various machine learning algorithms are used to produce predictive models.
Popular examples include Logistic Regression [117], Decision Trees [118], Naïve Bayes [119],
Random Forest [120], and (recently) Deep Neural Networks [121]. The training and optimization
of the machine learning models (including in some case feature selection) is typically done
through cross validation on the training datasets, with the intention to minimize overfitting. Once
the models perform adequately well on the training datasets, their predictive performance is
validated using independent (sharing low similarity with the training proteins) test datasets.
The dataset definition and preparation play a crucial role to instill trust for the built predictors.
The usual practice is to divide the currently available data into two parts: training set and test
set. Further, it is important to ensure that training dataset and test datasets are dissimilar from
each other, as measured by the protein sequence similarity. This similarity is usually reduced to
less than 30% between training set and test set. This way the test proteins cannot be accurately
predicted from the training proteins using sequence alignment. The training dataset is further
divided into several folds for the cross validation. In the cross validation, the training dataset is
divided into equally sized (in terms of number of proteins) x subsets (folds), and in the ith (1≤ i ≤x)
fold of the cross validation, x-1 subsets are used to train the model, and the remaining ith subset
is used as test set to evaluate the trained model. The results of the cross validation tests are
reported as the aggregate over all test folds or as an average over the x folds of tests.
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2.2.4

Evaluation of predictive performance

We use numerical evaluation criteria/metrics to assess the predictive quality of disorder and
disorder function predictors. These predictors typically generate two forms of outputs. The first
is the real-valued propensity for disorder (disorder function) that quantifies likelihood that a
given amino acid is disordered (has disorder function). The second is the is the binary prediction
where 0 usually means ordered (lacking given function) and 1 means disordered (having given
function). In fact, in most cases the binary prediction is generated from the propensities, such
that residues with propensities greater than or equal than a given threshold are predicted as
disordered (functional); otherwise they are predicted as ordered (non-functional).
One of the most common metrics that is used to evaluate the propensities is the area under the
receiver-operating curve (ROC-AUC). The ROC is a relation between true-positive rates (TPRs) and
false-positive rates (FPRs) that is computed by using many thresholds. Typically, the thresholds
are set to equal the set of all unique propensities produced by a given predictor. TPRs and FPRs
are calculated by comparing the native annotation of disorder/disorder function with the
predictions at different thresholds. TPR and FPR are defined as:
TPR =
FPR =

𝑇𝑇𝑇𝑇
𝑇𝑇𝑇𝑇
=
𝑇𝑇𝑇𝑇 + 𝐹𝐹𝐹𝐹 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑎𝑎𝑎𝑎𝑎𝑎 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

𝐹𝐹𝐹𝐹
𝐹𝐹𝐹𝐹
=
𝐹𝐹𝐹𝐹 + 𝑇𝑇𝑇𝑇 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑎𝑎𝑎𝑎𝑎𝑎 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑛𝑛𝑛𝑛𝑛𝑛 − 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑟𝑟𝑒𝑒𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠

where TP is the number of true positives (correctly predicted positives), FN is the number of false
negatives (positive residues that are predicted as negative), FP is the number of false positive
(negative residues that are predicted as positive), and TN is the number of true negatives
(correctly predicted negatives). Given TPR and FPR values generated at different thresholds
ranging from 0 and 1, we plot the ROC curve and calculate the corresponding AUC value. Note
that positive means disordered (having a given disorder function) while negative means ordered
(not having a given disorder function).
We note that the classification in the context of disorder/disorder function prediction is
imbalanced. Significant majority of residues are ordered/lack specific function. Thus, it is
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desirable to evaluate in the regime where we set a low false positive rate (FPR), e.g. at or below
5% or 10%. This ensures that the predictors do not over-predict the disorder/disorder function.
Correspondingly, we calculate AUClowFPR that covers the ROC curve for the low range of FPR values
(typically between 0 and 5%). Since AUClowFPR are rather small and difficult to assess directly, we
compute AUCratio = AUClowFPR/AUCrandom_lowFPR, where AUClowFPR is divided by the AUC of a random
predictor (for which FPR always equals to TPR) in the same FPR range. This ratio quantifies the
rate of improvement over a random predictor, i.e., ratio > 1 means that a given method is better
than random and ratio of two indicates that this method is twice better than random.
In addition to the calculating the AUClowFPR, another relatively popular measure to calculate the
predictive performance for an imbalanced dataset is the area under the precision recall curve
(PR-AUC). The PR-AUC is a functional relation between the precision and recall values computed
by using thresholds that binarize the propensity scores generated by the predictors. Higher
precision and higher recall values means lower false positive rate and lower false negative rate
respectively. This means that higher PR-AUC values correspond to more accurate predictions.
To evaluate the binary predictions, we use accuracy, precision, sensitivity and Matthews
Correlation Coefficient (MCC):
Accuracy =
Precision =

𝑇𝑇𝑇𝑇 + 𝑇𝑇𝑇𝑇
𝑇𝑇𝑇𝑇 + 𝑇𝑇𝑇𝑇
=
𝑇𝑇𝑇𝑇 + 𝑇𝑇𝑇𝑇 + 𝐹𝐹𝐹𝐹 + 𝐹𝐹𝐹𝐹
𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑎𝑎𝑎𝑎𝑎𝑎 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

𝑇𝑇𝑇𝑇
𝑇𝑇𝑇𝑇
=
𝑇𝑇𝑇𝑇 + 𝐹𝐹𝐹𝐹 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑎𝑎𝑎𝑎𝑎𝑎 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑑𝑑 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

Sensitivity =

𝑇𝑇𝑇𝑇
𝑇𝑇𝑇𝑇
=
𝑇𝑇𝑇𝑇 + 𝐹𝐹𝐹𝐹
𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑎𝑎𝑎𝑎𝑎𝑎 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

MCC =

𝑇𝑇𝑇𝑇 × 𝑇𝑇𝑇𝑇 − 𝐹𝐹𝐹𝐹 × 𝐹𝐹𝐹𝐹

�(𝑇𝑇𝑇𝑇 + 𝐹𝐹𝐹𝐹)(𝑇𝑇𝑇𝑇 + 𝐹𝐹𝐹𝐹)(𝑇𝑇𝑇𝑇 + 𝐹𝐹𝐹𝐹)(𝑇𝑇𝑇𝑇 + 𝐹𝐹𝐹𝐹)

The AUC ranges between 0.5 (equivalent to a random prediction) and 1 (perfect prediction).
Accuracy, precision and sensitivity range between 0 and 1 where 0 denotes that no residues were
predicted correctly and 1 denotes perfect prediction. MCC ranges between -1 and 1, where -1
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denotes that the prediction is inverted (all functional residues are predicted as non-functional
residues and vice versa), 0 denotes a random result and 1 denotes the perfect prediction.
We also emphasize the importance to measure the consistency of differences in the predictive
performance between two predictors, i.e., to assess statistical significance of the differences. We
place the n results from the two predictive models (e.g. using n test proteins) side by side, and
have n pairs of results. We use the Student’s paired t-test if both sets of the n results follow
normal distribution, and otherwise we use Wilcoxon signed-rank test. Student’s paired t-test
[122] evaluates two groups of data (e.g., two groups of AUC values), and determines whether
their mean values are significantly different. Wilcoxon signed-rank test [123] is an alternative to
student’s paired t-test when X1 or X2 does not follow normal distribution. It determines the
difference between the medians of X1 and X2. We use Anderson-Darling test (at the 5%
significance) to verify if a sample of n results follows the normal distribution. The AndersonDarling test [124] is a statistical test that checks whether a set of data follows a certain probability
distribution.

24 | P a g e

Chapter 3. Elucidation and comparative analysis of protein-level
predictive performance for current disorder predictors
This chapter describes work related to objective 1 from section 1.3. The results and methods
reported in this chapter were published in [125].
Large-scale evaluation of predictive quality for computational disorder predictors have received
substantial amount of attention [68-78]. These evaluations usually report popular metrics such
as area under receiver operating curve (ROC-AUC), accuracy, sensitivity, specificity, and MCC. The
usual practice is to evaluate these predictors at a dataset level without considering the
performance at the individual protein level. However, users typically apply these predictors to
individual proteins rather than large datasets.
This chapter investigates the predictive quality of selected disorder predictors at individual
protein level, besides the usually considered dataset level performance. We also contrast our
results with a few previously done dataset level assessments to ensure that our results crosscheck with these studies and to provide context for the protein level analysis. The first part
describes details of the benchmark dataset that we used and selection criteria that we used to
derive the list of the considered disorder predictors. Then we assess the selected set of
computational disorder predictors at both dataset and protein levels. The next section
investigates complementarity/similarity of predictive quality between the selected set of
predictors. The complementarity study intends to demonstrate differences and similarities
between predictive performance and the potential to use these methods in tandem. Finally, the
chapter presents a case study using a selected protein to demonstrate the predictions coming
from several different methods.

3.1 Related work in disorder predictor assessment
Several comparative assessments have been carried out in recent years to benchmark the
predictive quality of computational disorder predictors [15, 17, 18, 68-78, 126]. These
assessments compare the predictive performance of a given set of disorder predictors on a
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benchmark dataset. These benchmark datasets vary in size between 100 and 20 000 proteins.
The critical assessment of protein structure predictions (CASP) is one such bi annual assessment,
which considered disorder predictions from 2002 (CASP5) to 2012, (CASP10) [68, 73, 75-78]. CASP
experiments have used relatively small datasets with around 100 proteins. Some of the more
recent assessments rely on datasets from CASP10 experiment[13], use a larger datasets of 250
proteins collected from DisProt [18] and 500 proteins collected from PDB and DisProt[15]. The
evaluation with the largest dataset covers 13 predictors evaluated on a dataset of over 25 000
proteins[126]. Furthermore, a set 13 computational disorder predictors was assessed on dataset
of 350 membrane proteins [127]. A comprehensive survey of these assessments was done
recently in [128].
The results that are reported in the above assessments can be used to evaluate the relative
performance of the computational disorder predictors at the dataset level. None of the currently
available surveys focused on evaluating the disorder predictors at the individual protein level.
This is a noteworthy concern as arguably most of the time users characterize disorder for
individual protein rather than large-scale datasets. Many instances of the protein-level analysis
can be found in literature. For example, MFDp predictor[129], which was developed in our lab,
was used to predict disorder in flagella capping protein[130], Cia2[131], SpSM30B[132],
AP24[133] and BRCA1[134], among many other proteins.
We use Figure 3 to illustrate differences between the protein and the dataset level analyses. the
figure contrasts the dataset level predictive performance reported for few selected
computational disorder predictors in the recent large-scale assessment [126] with predictive
performance for a few selected proteins. The selected disorder predictors include three methods
that are characterized by different ranges of the dataset level performance: GlobPlot on the
lower end, IUPred for medium performance, and VSL2b for high end, according to the considered
assessment. The evaluation measure is ROC-AUC that ranges from 0.5 to 1.0. The reported
dataset level performance for GlobPlot, IUPred and VSL2b are 0.631, 0.726 and 0.821
respectively. The individual predictive performance for the proteins such as guanylate kinase (red
marker in Figure 3; UniProt Q2GLF7) and phytoene desaturase (blue marker; UniProt P21685) are
in sync with the datasets-level AUCs. At the same time, for nonhemagglutinin type D (green
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marker in Figure 3; UniProt Q9LBR2) the protein level performance varies substantially from the
dataset level performance. The GlobPlot’s performance for this protein is considerably better
than its dataset level performance while the results of the other two predictors are similar to
their dataset-level performance. In this case, the worst at the dataset level GlobPlot outperforms
the other two methods. Another interesting example is hydroxymethyltransferase (orange
marker in Figure 3; UniProt P0A5Q8) where the highest predictive performance is provided by
IUPred, while the dataset-level assessment shows that VSL2B outperforms IUPred. Overall, all
three predictors outperform their corresponding dataset-level results for this protein. The
alkaline phosphatase protein (violet marker; UniProt A1YYW7) is predicted poorly by both
GlobPlot and IUPred, at level much lower than their dataset-level benchmark suggests, while the
predictions from VSL2B substantially outperforms its dataset-level AUC.

Figure 3: Comparison of the benchmark (dataset-level) and protein-level predictive performance
measured with AUC for three disorder predictors (GlobPlot, IUPred and VSL2B) and five color-coded
proteins: non-toxic nonhemagglutinin type D (green marker; UniProt Q9LBR2), guanylate kinase (red
marker; UniProt Q2GLF7), alkaline phosphatase (violet marker; UniProt A1YYW7),
hydroxymethyltransferase (orange marker; UniProt P0A5Q8) and phytoene desaturase (blue marker;
UniProt P21685). The benchmark AUC values are shown on the x-axis, while the protein-level AUC values
are color-coded, shown on the y-axis and their values are given next to the corresponding markers. The
black isometric AUC line shows equivalent dataset-level and protein-level values. Published in [125]
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Altogether, Figure 3 clearly illustrates that protein level predictive performance can vary
considerably from the dataset level results that are reported by previous assessments. This
chapter assesses and investigates variability of the protein level predictive performance, and
contrasts these results with the dataset level performance for a set of 13 representative disorder
predictors using a large dataset of 6,271 proteins.

3.2 Benchmark datasets and selection of disorder predictors
This evaluation was done on a protein dataset with disorder annotations that was originally used
in the large prior dataset-level assessment [126]. The initial dataset in that study included 25,717
proteins for which annotations, disorder predictions and protein sequences were extracted from
the MobiDB database [66]. We improved the original dataset to remove low quality protein
sequences and to reduce redundancy, i.e., the datasets includes many clusters of similar proteins
that could skew results toward these over-represented protein families. We removed sequences
with unknown/undetermined amino acid (AA) types, which is required to generate disorder
predictions, and by reducing within-dataset redundancy. We used BLASTCLUST[135] to cluster
proteins with over 25% similarity and we selected one protein from each cluster. The final dataset
has 6,271 proteins that share <25% similarity and that include 105,709 disordered and 1,672,907
structured residues. This dataset was also utilized in another study that investigates quality
assessment of disorder predictions [136]. This study shows that the predictive performance of
the disorder predictors on the original dataset of 25,717 proteins that was assessed in [126] is
very similar to the performance on the improved benchmark dataset with 6,271 proteins [136].
We selected a diverse set of 13 publicly available computational disorder predictors for our
analysis. Ten out of the 13 predictors were used in the previous large scale assessment [126]. The
selected 13 predictors include three versions of ESpritz that predict intrinsic disorder annotated
from x-ray structures (ESpritz-Xray), NMR structures (ESpritz-NMR) and using DisProt database
(ESpritz-DisProt)[65]; the two versions of IUPred that are separately optimized to predict short
IDRs (IUPred-short) and to predict long IDRs (IUPred-long)[52]; the two versions of DisEMBL
which are developed for X-ray structures (DisEMBL-465) and to predict IDRs that form loop
secondary structures (DisEMBL-HL)[54]; GlobPlot[51], RONN[53] and VSL2B[57]. We excluded
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three methods SEG [137] , Pfilt [138] and FoldIndex [139] that were used in the previous
assessment, considering that they are rather old and that their dataset level predictive
performance is low [126]. Furthermore, we added three recent disorder predictors: DISOPRED3
[112] (that performed very well in CASP10 [73]) and two recently published deep learning-based
methods: SPOT-Disorder [112] and DeepCNF-D [82]. We use the fast version of DeepCNF-D
(DeepCNF-D ami_only) given the large size of our dataset. These methods were published
between 2002 and 2016 (work presented in this chapter was done in 2017 and 2018) and most
of them use machine learning-based predictive models. They are well-cited, with the annual
number of citations ranging between 5 (for the new methods) and 50. The selected predictors
uniformly cover the three categories of methods (Section 2.2.1) including ab-initio tools (IUPredshort, IUPred-long and GlobPlot), machine learning-based predictors (RONN, DisEMBL-HL,
DisEMBL-465, VSL2B, DeepCNF-D and SPOT-Disorder) and meta-predictors (DISOPRED3, ESpritzXray, ESpritz-NMR and ESpritz-DisProt). They were designed to address prediction of all major
types of disorder annotations including annotations that rely on x-ray crystal structures, NMR
structures and a variety of other experimental methods that are covered in the DisProt resource.
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Table 5: Dataset- and protein-level predictive quality for the 13 considered disorder predictors. The dataset-level accuracy and AUC are compared
against the previously published results. We note that false positive rates are typically not reported in the past studies. Protein-level results are
summarized with the median value. The methods are sorted by their dataset-level AUC on our benchmark dataset. These results were published
in [125].

Disorder
predictor
GlobPlot
disEMBL-HL
IUPred-long
JRONN
ESpritz-NMR
IUPred-short
disEMBL-465
ESpritz-Xray
VSL2B
ESpritz-DisProt
DeepCNF
DISOPRED3
SPOT-Disorder
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FPR (binary predictions)
Accuracy (binary predictions)
AUC (putative propensities)
Previously
Previously
ProteinDifference
Difference
reported
Protein-level Datasetreported
DatasetProtein-level
Dataset-level
level
datasetdatasetmedian
datasetlevel
datasetlevel
median
median
level
level
level
level
0.876
0.855
0.847
0.8%
0.662
0.626
0.631
0.5%
0.090
0.111
0.715
0.713
0.721
0.8%
0.780
0.725
0.727
0.2%
0.282
0.277
0.945
0.922
0.921
0.1%
0.798
0.732
0.726
0.6%
0.012
0.040
0.848
0.847
0.839
0.8%
0.824
0.772
0.759
1.3%
0.132
0.131
0.931
0.905
0.903
0.2%
0.879
0.776
0.770
0.6%
0.041
0.068
0.934
0.921
0.924
0.3%
0.852
0.778
0.778
0.0%
0.043
0.051
0.931
0.921
0.925
0.4%
0.835
0.780
0.787
0.7%
0.047
0.049
0.904
0.849
0.840
0.9%
0.904
0.796
0.778
1.8%
0.071
0.136
0.832
0.816
0.805
1.1%
0.874
0.810
0.821
1.1%
0.161
0.177
0.959
0.917
0.934
1.7%
0.861
0.816
0.791
2.5%
0.000
0.034
0.952
0.936
0.944
0.8%
0.926
0.871
0.898
2.7%
0.027
0.033
0.977
0.957
0.955
0.2%
0.969
0.899
0.897
0.2%
0.004
0.016
0.971
0.956
0.950
0.6%
0.969
0.904
0.891
1.3%
0.011
0.018

3.3 Predictive performance of disorder predictors
3.3.1

Dataset level predictive performance

Table 5 provides dataset level predictive performance of 13 disorder predictors on the
benchmark dataset with 6,271 proteins. Furthermore, this analysis contrasts the dataset level
performance with previous assessments. The previously published performance for the
DISOPRED3 comes from CASP10 [79], for SPOT-Disorder from [59] and for DeepCNF from [82].
The other ten predictors were assessed in [126]. The “difference form dataset level” columns
show the percentage of the differences between the previously reported results and the
assessment on our dataset for the accuracy and AUC measures. The average differences (over
the 13 predictors) in accuracy and AUC are 0.67% and 1.04%, respectively. This shows that our
analysis that uses a larger dataset closely reflects the current state of the per-dataset
assessments. The results are also in agreement with the previous assessments showing that
DeepCNF, SPOT-Disorder and DISOPRED3 outperform the other 10 disorder predictors.
3.3.2

Protein level predictive performance

The analysis of the protein level predictive performance explores the per protein distributions of
three commonly used criteria of the predictive performance: AUC, accuracy (ACC) and false
positive rate (FPR). Figure 4 illustrates distribution of these metrics over the 6,271 proteins. The
distributions of the accuracy and AUC metrics for all predictors are right-skewed with long tails.
The corresponding distributions of the FPR values are left-skewed with similarly long tails; this is
because larger values of FPR indicate lower predictive quality. These distributions demonstrate
that while majority of the proteins are predicted with above average predictive performance,
minority of proteins that are located in the long tails are predicted with low performance.
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Figure 4: Distributions of the protein‐level predictive quality measured with accuracy (green plots), AUC
(blue plots) and false positive rate (FPR; red plots) for the 13 disorder predictors. The y‐axis gives the
fraction of the proteins in a given range of accuracy/AUC/FPR values. These results were published in
[125].

The above distributions are summarized and compared with the corresponding dataset level
results in Figure 5. Panels 5A, 5B and 5C show accuracy, ROC-AUC and FPR, respectively. The box
plots show the first quartile (in red), second quartile (median; where red and green meet) and
third quartile (in green), with whiskers that denote the 10th and 90th percentiles. The long tails
are represented by the long bottom whiskers for accuracy and AUC (long top whiskers for FPR)
when compared to the corresponding top whiskers (bottom whiskers for FPR). The black
horizontal lines denote the dataset-level values. Figure 5 reveals that majority of the proteins
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secure higher levels of predictive performance than their corresponding dataset-level
assessment suggests. Furthermore, protein-level medians for accuracy and AUC are consistently
higher or at worst similar to the dataset-level values, while the protein-level medians for FPR are
consistently lower or similar when compared to the dataset-level values. These values can be
directly compared in Table 5. This trend is consistent across the 13 disorder predictors and the
three measures of predictive performance.

Figure 5: Distributions of the protein-level predictive quality measured with accuracy (panel A), AUC
(panel B) and false positive rate (panel C) for the 13 disorder predictors. Box plots show the second
quartile (in red), median (between red and green boxes) and third quartile (in green) for the distribution
of the protein-level values. The whiskers denote the corresponding 10th and 90th percentiles. The black
horizontal lines show the benchmark dataset-level performance. The predictors are sorted by their
median values of the predictive performance. These results were published in [125].

We observe that the fraction of proteins for which performance is better than the dataset level
estimate varies between the disorder predictors. Proteins for which a given predictor performs
better than expected (i.e., better than its dataset level estimate) are denoted as easy-to-predict
proteins and proteins which it performs lower than expected (i.e., lower that its dataset level
estimate by a margin equal to the average difference of the pairwise comparison of all predictors)
are denoted as hard-to-predict proteins. The value of the margin equals 0.067 and 0.071 for
accuracy and AUC, respectively. Figure 6 illustrates the rates of the hard-to-predict and easy-topredict proteins for each disorder predictor evaluated with AUC and accuracy (ACC).
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Figure 6: Analysis of the easy- and hard-to-predict proteins for the 13 disorder predictors. The easy
proteins are predicted with higher-than-expected accuracy or AUC, i.e. their protein-level accuracy
(AUC) > dataset-level accuracy (AUC). The hard proteins are predicted with relatively low accuracy or AUC,
i.e. their protein-level accuracy (AUC) < (dataset-level accuracy (AUC) – average margin of difference
between disorder predictors). Bars represent the fraction of the easy proteins (green bars) and the hard
proteins (red bars) when predictive performance is quantified with AUC (dark shade) and accuracy (light
shade). Predictors are sorted by fraction of the easy proteins quantified with AUC (dark green bars). These
results were published in [125].

When it comes to AUC, between 57% of proteins (for GlobPlot) and 75% of proteins (for
DISOPRED3) are easy to predict, i.e., their predictive performance higher than the expected
value. Similarly, between 50% (for JRONN) and 69% (for DISOPRED3) of proteins have better than
expected accuracy. Red bars in Figure 6 quantify the abundance of the hard-to-predict proteins.
Figure 6 shows that between 14% of proteins (for SPOT-Disorder) and 32% of proteins (for
ESpritz-DisProt) are hard-to-predict with respect to their AUCs. Similarly, the analysis reveals that
between 9% (for DISOPRED3) and 30% (for disEMBL-HL) of proteins have lower-than-expected
accuracy. This means that the users should expect low-quality protein-level predictions for
anywhere between 10% (for accurate predictors like DISOPRED3 and SPOT-Disorder) and 30%
(for less accurate predictors like JRONN and disEMBL-HL) of proteins that they submit. In other
words, the end users will be unpleasantly surprised with their results for anywhere between 1 in
10 proteins to 3 in 10 proteins.
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A few studies have reported that predictive performance of disorder predictors is sensitive to the
native protein-level disorder content [17, 59, 126]. The trend that they observe is that
performance on proteins with a substantial amount of disorder is lower compared to the proteins
with little to no disorder. We investigate this trend by comparing the protein-level accuracy
against the protein sequence length and fraction of the disordered residues. The Pearson
correlation coefficients (PCCs) computed for accuracy vs chain length for the 13 disorder
predictors are low and range between 0 and 0.37, with the average of 0.12. In contrast, the PCCs
between disorder content and accuracy are relatively high and vary between −0.14 and −0.75,
with the average of −0.42. The negative sign implies that, as expected, proteins with more
disorder score (on average) lower predictive performance.

Figure 7: Relation between the protein-level predictive performance and the native disorder content.
Panel A shows medians of the average (over the 13 predictors) accuracy and AUC for proteins grouped by
their native disorder content, defined as the fraction of disordered residues in the sequence. The whiskers
give the 10th and 90th percentiles of these averages. Panel B gives the distribution of the disorder content
for the easy and hard proteins that are in common across the 13 predictors. The box plots show the 2nd
quartile, median (black horizontal line and 3rd quartile for the distribution of the protein-level disorder
content values. The whiskers denote the corresponding 10th and 90th percentiles. These results were
published in [125].

We further analyze the relation between disorder content and the predictive performance in
Figure 7. Figure 7A shows average predictive performance of the 13 computational disorder
predictors for proteins binned into discrete ranges based on their disorder content. This Figure
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shows a clear trend of declining predictive performance with the increasing native disorder
content for both metrics: AUC and ACC. The predictive performance stays relatively high until the
native disorder content stays below 0.5 and drops substantially when the disorder content
exceeds 0.7. The median values of the average protein-level accuracy and AUC equal only to
0.387 and 0.642, respectively, for the proteins which has disorder content above 0.7. The
whiskers, which denote the 10th and 90th percentiles, reveal that many proteins with over 0.7
disorder content secure near random levels of accuracy and AUC. Figure 7B illustrates this
relation using the previously defined sets of easy-to-predict and hard-to-predict proteins. It
compares the distribution of the disorder content between these two proteins sets. It is clear
that the easy-to-predict proteins have much lower disorder content in the case of both metrics:
AUC and accuracy. These findings are relatively troubling, as they reveal that the current disorder
predictors perform relatively poorly for the proteins where they are arguably needed the most
(proteins with the most disorder).

3.4 Complementarity and relative protein-level performance of disorder predictors
This section investigates significance of differences in the predictive performance for the 13
predictors and also analyzes complementarity of their predictions. First, we quantify the
significance of the differences. The results are shown using arrows in Figure 8. We assume that a
given pair of predictors is significantly different if the corresponding p-value < 0.01. The analysis
suggests that majority of the differences are significant, which means that the improvements are
consistent across majority of proteins. When it comes to the ROC-AUC, the difference between
the best performing SPOT-Disorder and DISOPRED3 is not significant, while they both significantly
outperform the other 11 disorder predictors. In terms of accuracy, DISOPRED3 significantly
outperforms the other 12 disorder predictors. ESpritz-DisProt that has the lowest median
protein-level FPR and has significantly lower FPR values when contrasted with each of the 12
other predictors. The reason behind this low FPR for ESpritz-DisProt is that it under-predicts the
amount of disorder. This was also shown in [136], where ESpritz-DisProt predicts 2.6% disorder
content in a large dataset with 5% native disorder content, while the other nine methods
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considered in that article predict disorder content between 6% (IUpred-long) and 29% (DisEMBLHL).

Figure 8: Comparison of the protein-level predictive performance between the 13 disorder predictors.
Panel A summarizes comparison of the AUC values (on green background) and accuracies (on blue
background). Panel B considers the false positive rates (on red background). Statistical significance of the
differences between all pairs of methods was assessed with the t-test for normal measures and otherwise
with the Wilcoxon rank-sum test. Normality was tested with the Anderson–Darling test at 0.05
significance. We assume that the difference in predictive performance for a given pair of predictors is
significant if the corresponding P-value is <0.01. Arrows point to the methods that secure significantly
better predictive performance (P < 0.01). The P-values are shown for the pairs of methods that are not
significantly different. These results were published in [125].

We analyze complementarity of the 13 computational disorder predictors by computing the
Pearson’s correlation coefficients (PCCs) for each pairwise comparison of the protein-level AUCROC and accuracy values. Figure 9 illustrates the mutual correlation grid for accuracy and ROCAUC in panel A and panel B, respectively. The color-coding is used to denote different ranges of
PCC values where red denotes weak correlation (PCC < 0.3); yellow denotes modest correlation
(0.3 > PCC > 0.66) and green denotes high correlation (PCC > 0.66). We find two clear clusters of
computational disorder predictors when performing assessment with accuracy (Figure 9A). The
low correlation cluster (shown in red) includes six disorder predictors: disEMBL-HL, ESpritzDisProt, ESpritz-Xray, ESpritz-NMR, GlobPlot and DISOPRED3. The high correlation cluster (shown
in green) has three sub cluster groups as follows: i) VSL2B and JRONN; (ii) IUPred-long, IUPredshort, disEMBL-465 and DeepCNF; and (iii) disEMBL-465, DeepCNF and SPOT-Disorder. Figure 9B
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illustrates this analysis for ROC-AUC. We identify three highly correlated (green) clusters: (i)
ESpritz-Xray and DeepCNF; (ii) disEMBL-465, JRONN, VSL2B, IUPred-long, IUPred-short and
disEMBL-HL; and (iii) SPOT-Disorder and DISOPRED3. Overall, we show that certain methods
provide similar levels of predictive performance for the same proteins while they differ
substantially from other predictors. This opens an interesting and worth further pursuit
opportunity to design meta-predictors that combine results produced by multiple disorder
predictors to improve predictive performance.

Figure 9: Pearson correlation coefficients (PCCs) between the protein-level predictive performances for
each pair of the considered 13 disorder predictors. Panels A and B quantify the performance with accuracy
and AUC, respectively. Both correlation matrices are symmetric. The sorting of the predictors differs
between the two panel and was optimized to highlight clusters of highly correlated methods. Values of
the PCC are color-coded where red denotes no correlation (PCC < 0.3), yellow denotes modest correlation
(0.3 ≤ PCC ≤ 0.66) and green corresponds to high correlation (PCC > 0.66). These results were published in
[125].

Along the lines of the complementarity analysis, we assess contributions of individual disorder
predictors to produce high quality predictions at the protein level. Figure 10A shows the fraction
of proteins for which a given disorder predictor generates the most accurate result, as quantified
with the accuracy (inner ring) and AUC (outer ring). The best performing at the dataset-level
DISOPRED3 and SPOT-Disorder provide the best protein-level results for only about half of the
proteins. Moreover, each of the 13 tools generates the most accurate protein-level predictions
for some proteins. This includes the worst dataset-level performers, GlobPlot and disEMBL-HL,
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which provide the best accuracies for 0.9% and 0.5% of proteins, respectively, and the highest
AUCs for 0.9% and 1.7%, respectively. Figure 10B breaks down the proteins for which a given
number of predictors offers highly accurate predictions, i.e. predictive quality that is higher than
the expected quality of the best method (the dataset-level performance of the best method). The
Figure reveals that only less than 19% of proteins lack highly accurate predictions (dark red
regions in Figure 8B). Furthermore, over half of the proteins secure highly accurate predictions
(measured with either accuracy or AUC) by at least four disorder predictors, while 25% of proteins
(when using accuracy) and 39% of proteins (when using AUC) have such accurate predictions
produced by the majority of the 13 disorder predictors. The bottom line is that high-quality
protein-level predictions can be often obtained from several disorder predictors. This suggests
that the end users should not limit themselves to using only the most accurate (at the datasetlevel) methods.

Figure 10: Contributions of the 13 disorder predictors to the production of the highly accurate predictions.
Panel A quantifies the fraction of proteins for which a given method generates the highest predictive
performance compared to all other disorder predictors. Panel B show the fraction of proteins for which a
given number of predictors offer highly accurate predictions, i.e. predictive performance that is higher
than the expected performance of the best method (the dataset-level performance of the best method).
The inner and outer rings show results when using accuracy and AUC, respectively. These results were
published in [125].
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3.5 Case Study
This section demonstrates predictions from five selected computational disorder predictors for
hydroxymethyltransferase from Mycobacterium tuberculosis (Uniprot id: P9WIL7). The native
disorder annotation for this protein was obtained from missing electron densities in PDB crystal
structures (PDB ID: 1OY0). Figure 11 illustrates predictive propensity scores and binary
predictions from DISOPRED3, SPOT-Disorder, VSL2B, IUPred-long and GlobPlot. These five
computational disorder predictors are selected to represent three different ranges of the overall
predictive performance: DISOPRED3 and SPOT-Disorder for high quality predictions; VSL2B and
IUPred-long for medium range and the GlobPlot for the low quality range. The selected five
predictors comfortably exceed their dataset-level ROC-AUCs for this protein: DISOPRED3
(AUC = 0.96 for this protein versus 0.90 at the dataset-level), SPOT-Disorder (0.96 versus 0.90),
VSL2B (0.88 versus 0.81), IUPred-long (0.93 versus 0.73) and GlobPlot (0.80 versus 0.63). The
native disorder annotation for this protein includes three disordered regions (shown in red in
Figure 11). While the N-terminus region is was predicted reasonably well by all five disorder
predictors, the short IDR at the C terminus is detected by only three out of five predictors.
Moreover, only GlobPlot and IUPred-long found the disordered region in the middle of the

sequence. The very high AUCs of SPOT-Disorder and DISOPRED3 comes from the fact that these
methods produce high propensities for the disordered region at the N-terminus while also
predicting low propensities for the structured regions. Moreover, outputs of these two methods
show spikes in their predicted propensities near the two other disordered regions. While these
spikes are not high enough to trigger generation of the binary disorder prediction (they are below
their thresholds shown using the dashed horizontal lines), they suggest that disorder is more
likely in these regions than in the other parts of this sequence. Overall, this case study shows how
the disorder predictors beat their dataset-level predictive performance, which is a typical
scenario that we revealed in this analysis.
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Figure 11: A case study that compares disorder predictions for the hydroxymethyltransferase protein from
M. tuberculosis (Uniprot id: P9WIL7) that were generated by five methods: VSL2B (dark green), SPOTDISORDER (magenta), DISOPRED3 (orange), GlobPlot (lime) and IUPred-long (gray). The putative
propensities are shown using the solid, color-coded lines. The corresponding binary predictions are given
using the color-coded horizontal bars at the bottom of the figure; thresholds that are used to convert the
propensities into the binary predictions are visualized with the dashed horizontal lines in the top part of
the figure. The red and blue horizontal bar denotes the native annotation of disordered and structured
regions, respectively, which were annotated using crystal structure (PDB ID: 1OY0). These results were
published in [125].

3.6 Summary
This chapter addresses assessment of the computational disorder predictor from a novel and
important viewpoint. Our first-of-its-kind large-scale analysis of 13 representative disorder
predictors shows that the quality of the protein-level predictions is often very different from the
corresponding dataset-level results. This assessment shows that the protein-level predictive
performance is in fact higher than the corresponding dataset-level assessments values for a
significant majority of proteins, as of many as over 70% of proteins for the ESpritz-Xray, SPOTDisorder and DISOPRED3 methods. However, at the same time, we show there are also relatively
many poorly predicted proteins for every considered disorder predictor. The fraction of the poor
predictions falls within the range of 10% to 30% of the proteins.
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Our investigation further reveals that the predictive performance of disorder predictors is
correlated with the amount of the native disorder content in a given protein. We observed a
trend where performance of disorder predictors drops for proteins with higher disorder content.
We demonstrate that easy-to-predict proteins are characterized by low amounts of disorder
while the hard-to-predict proteins typically have substantial amounts of disorder. Furthermore,
we investigate complementarity of the predictive performance across the 13 disorder predictors
as well their relative performance. We show that while two methods, SPOT-Disorder and
DISOPRED3, are significantly better than the other predictors, the other methods also provide
good quality results for some of the proteins.
Our analysis suggests that disorder predictors provide complementary results. This reveals an
interesting opportunity to develop a recommender system that would suggest the most suitable
disorder predictor(s) for a given protein sequence. This recommendation system would need to
rely on accurate linking of unique characteristics of the input protein sequence, such as
physiochemical properties of its amino acids, with the predictive performance of a given
predictor. The motivation to pursue this objective comes from the large number of the available
disorder predictors, which as we show offer complementary results, and the fact that end users
would be undoubtedly overwhelmed by the task of selecting a suitable predictor for their protein
of interest.
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Chapter 4. Development of a novel protein-level predictor
recommendation system to improve predictive performance of
disorder predictions
The previous chapter investigated predictive performance of computational disorder predictors.
It concludes that the performance cannot be simply represented by the dataset level values and
it also must consider results for individual proteins. Furthermore, Chapter 3 has revealed that
some of the current disorder predictors perform in a complementary fashion when tested on
individual proteins. In other words, some predictors may perform very well while some other
may secure poor performance on the same protein, irrespective of their performance on
benchmark datasets.
Motivated by the findings from Chapter 3, here we describe the work towards objective 2 that
we define in Section 1.3. The results and methods reported in this chapter were published in
[140]. This chapter investigates answers to two questions:
1. Is it possible to predict the predictive performance of a given disorder predictor for a
given protein?
2. Given that answer to question one is positive, could this prediction be used to identify
well-performing disorder predictors for a given protein?
We cover a comprehensive set of 12 disorder predictors representing the three categories of
methods that were described in Section 2.2.1. These computational disorder predictors are
selected based on their relatively low runtime, availability and previously reported predictive
performance. The estimation of the predictive performance for given proteins is based solely on
the physiochemical properties of the input amino acid sequence and hence the only input that
we use is the readily available sequence. The overarching goal is to suggest the disorder predictor
that provides the highest performance for a given input protein sequence. As a byproduct of our
approach, we will also offer an estimate of the expected predictive performance that will be
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produced by the selected predictor, giving the end users useful information whether to pursue
the prediction and suggesting which particular predictive tool to use.

4.1 Protein-level predictive performance of disorder predictors
We use the AUC-ROC as the performance evaluation measure. This is the most widely used metric
to evaluate the predictive performance of disorder predictors [13, 15, 18, 79, 128].
This section evaluates per protein ROC-AUC for 12 representative computational disorder
predictors that include three versions of ESpritz that predict intrinsic disorder annotated from xray structures (ESpritz-Xray), NMR structures (ESpritz-NMR) and using DisProt database (ESpritzDisProt)[59]; the two versions of IUPred that are optimized to predict disorder short regions and
disorder long regions (IUPred-short and IUPred-long, respectively)[48]; the two versions of
DisEMBL which cover X-ray structures (DisEMBL-465) and loop secondary structures (DisEMBLHL) [50]; GlobPlot [47], RONN [49], VSL2B [53], DISOPRED3 [100] and SPOT-Disorder [100]. The
evaluation was done on the dataset of 5,272 proteins that was described in the Section 3.2. Since
calculation of AUC requires presence of both disordered (positive) and ordered (negative)
residues, we limit this analysis to proteins that have at least four ordered and at least four
disordered residues. Figure 12 illustrates distribution of ROC-AUC values for the corresponding
set of 3,621 proteins and the 12 selected predictors.

44 | P a g e

Figure 12: Distribution of per‐protein AUC values 12 computational disorder predictors over 3,126
proteins in the benchmark dataset. These results were published in [140].

Virtually all considered disorder predictors, except for GlobPlot, have long tails of poorly
predicted proteins and the bulk of the predictions characterized by high ROC-AUC values, which
agrees with results from Chapter 3. This shows that this pattern of predictive performance is not
affected by the above selection of the proteins that have both disordered and structured
residues. The DISOPRED3 predictor has the highest reported dataset level ROC-AUC of 0.9 [17]
and it secures a sharp peak with relatively low but still fairly long tail of poor-quality predictions.
As another example, VSL2B has lower dataset level ROC-AUC of 0.82 [126] and we observe a
wider peak with a bigger tail when compared to DISOPRED3. As we noted in Chapter 3, AUC
values for individual proteins vary widely from the dataset‐level values. For instance, for VSL2B
that has the dataset‐level AUC = 0.82, Figure 12 reveals that 59.2% proteins have AUCs >0.9 while
9.3% of proteins are predicted with AUCs <0.6. Similarly, for DISOPRED3 that has the dataset‐
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level AUC = 0.90, 9.5% of proteins are predicted with AUCs <0.8 while 68.5% have AUCs >0.95.
This wide range of the per-protein predictive performance motivates the development of a tool
that estimates performance for a given protein.

4.2 Experimental workflow
We aim to develop a system that recommends a well-performing predictor for a given protein
sequence. The first step is to predict the expected ROC-AUC for a given protein and a given
disorder predictor. Next, we simply recommend the predictors with the highest predicted
performance. This system offers practical value in two novel ways. The first is to assist the users
in selection of a good disorder predictors for a specific protein. This is valuable even for
experienced end users who are well-informed about the availability and quality of different
disorder predictors. This is because the benchmark results for disorder predictor may vary widely
from their protein-level performance. The second is to offer an estimate of the performance that
will be produced by the selected predictor. This will inform the user to which extend they can
trust the prediction and will allow them to judge whether to pursue the prediction in the first
place.
4.2.1

Architecture and design of the protein-level predictors of disorder prediction quality

This first step provides estimate of the expected ROC-AUC values of a disorder predictor for a
given input protein. These estimates are produced by machine learning models. Figure 13
illustrates the architecture of the proposed method. Panel (a) gives the flowchart while panel (b)
provides a pseudocode for this prediction process.
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Figure 13: Architecture of the proposed recommendation system. Panel (a) gives flowchart of the proposed model while panel (b) shows the
corresponding pseudocode. This illustration was published in [140].
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The prediction begins by collecting the amino acid sequence of the proteins as the sole input.
Next, we use the amino acid sequence to generate a sequence profile that provides additional
residue-level information about the input protein. This sequence profiles consist of a few
physicochemical and structural properties that are related with presence of disorder [25, 32, 48,
141-145]. They include two putative structural properties generated by third-party predictors:
solvent accessibility predicted with ASAquick [146] and secondary structure predicted with the
single sequence version of the PSIPRED [147]. The selection of these structural predictors was
based on their availability and computational efficiency. The profile also includes sequence
complexity generated by the SEG algorithm [137] and a few sequence-derived physicochemical
properties like hydrophobicity, hydropathy, charge, structural entropy, polarity, volume, size,
flexibility, refractivity, transfer and solvation energies, and propensity for coil, turn, strands, helix
and disordered conformations. These physicochemical properties rely on the corresponding
indices that we collected from AAindex database [148]. We encode the sequence profile into a
vector of 130 numeric features that aggregate the information concerning structural and
physiochemical properties at the whole‐protein level. These features are detailed in the
Appendix 1. They include 21 features computed directly from the input sequence (AA
composition and sequence length), 3 features computed from the putative solvent accessibility,
2 features from the sequence complexity, 8 features from the putative secondary structure, and
96 features based on the physiochemical properties.
Figure 13 summarizes the architecture of our predictive models using the 3-layer design. The
layers 1 and 2 refer to the generation of the feature vector from the sequence profile which is
processed by the predictive model, in the form of a regression tree. We performed feature
selection and optimization of the predictive model using the training set of 5,272 proteins
described in Section 3.2. From the machine learning perspective, this task is a regression problem
where each machine learning model is trained to predict the expected ROC-AUC for a given
disorder predictor.
The feature selection was done in two steps. First, features with high mutual correlation were
removed in order to filter out similar features. We quantified the mutual similarity for all pairs of
the 130 features based on the Pearson correlation coefficients (PCCs). For each pair of highly
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correlated features (|PCC| > 0.65), one of them that has lower predictive performance was
removed. The predictive performance was measured based on the PCC with the per‐protein AUC
scores for a given disorder predictor. This step resulted in the removal of between 21 and 40
features, depending on the predictor.
Next, we removed features that have low predictive power via wrapper-based feature selection,
done separately for each of the 12 disorder predictors. In short, we screened features by their
ROC-AUC values when used individually to predict the protein-level AUCs of a given disorder
predictor. A subset of features with |PCC| > threshold was selected, where the value of the
threshold was selected to provide the highest predictive quality assessed by the three fold cross
validation on the training set. The threshold during was gradually increased by 0.01 starting from
0 until the cross-validated PCC between actual ROC-AUC and predicted ROC-AUC drops. The
selected feature sets ranged in size between 24 and 38, depending on the disorder predictor
used.
As part of the wrapper-based feature selection and optimization of the predictive model, we
considered three types of regression models: nearest neighbor regression [149], linear regression
[150], and extra tree regression [151]. The corresponding average (over different disorder
predictors) PCCs on the training set were 0.15, 0.13 and 0.31, respectively. The average mean
squared error (MSE) values for the same three algorithms were 0.018, 0.011 and 0.007,
respectively. Hence, the extra tree regression was selected the best performing predictive model.
The extra tree regressor is an enhanced version of extremely randomized random forests that
relies on randomization to grow trees [152]. The key objective behind this randomization is to
minimize overfitting into the training set. The avoidance of overfitting is specifically important in
our case as the training set and test set share low (<25%) similarity. Furthermore, the extra tree
regression is more computationally efficient than the conventional random forests. We
parametrized our regression models via a grid search for each of the 12 disorder predictors, with
the aim to maximize the PCC for the 3-fold cross validation on the training dataset. For instance,
for the extra tree regression we parameterized the maximum depth of the trees (using 0–20
range), number of trees in the forest (100–180 range), minimum number of samples required for
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a split (0–30 range), and the number of features to consider when calculating best split (0–50
range).
4.2.2

Design of the protein-level disorder predictor recommendation system

In the second step the 12 extra tree regression-generated estimates of ROC-AUCs are processed
and compared and the disorder predictor with the highest expected ROC-AUC is recommended
to the user. More specifically, predictions from each of the 12 regressors are mapped into the
distribution of AUCs values from the training datasets for the corresponding disorder predictor
(third layer in Fig. 13). This ensures that the predicted AUCs are calibrated to cover the entire
spectrum of AUC values that are produced by a specific disorder predictor. Finally, the 12
predicted AUCs are compared and the method with the highest putative AUCs is recommended
back to the user. We call the complete recommendation system DISOselect. The outputs
generated by DISOselect include the recommended disorder predictor, its putative AUC and the
AUC values for each of the other 11 predictors.
4.2.3

Analysis of the predictive model

This section investigates how our model accomplishes the prediction of the expected AUCs
values. More specifically, we analyze relation between the input features and the output (AUC
values). We investigate individual features produced in the layer 1 of the model (Figure 13) and
the importance of specific features groups to the predictive performance of the extra tree
regressor.
In order to analyze the contribution of individual features, we focus on the top two features with
the highest PCC with the output for each of the 12 considered disorder predictor. After selecting
top two most correlated features, we obtained 18 features since some of these features were
shared by multiple disorder predictors. The predictive value of these features is summarized in
Figure 14 where darker shading corresponds to a higher magnitude of correlation with the output
(stronger contribution to the model). The direction of the arrows denotes the sign of the
correlation where upwards pointing arrows are for positive correlation and downwards pointing
arrows are for negative correlations.
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As one highlight, we observe that the average accessible surface (ASA) area is a strong contributor
to our model (bottom of Figure 14). Interestingly, ASA is positively correlated with the SPOT‐
Disorder’s and DISOPRED3’s AUCs, but negatively correlated with the ESpritz‐DisProt’s
performance. In general, we note that virtually all features switch the sign of the correlation
when used to make predictions for different disorder predictors. This demonstrates each
disorder predictor has its own unique predictive pattern. Individual performance biases may
reflect the makeup of the training sets and the selection of the sequence‐derived predictive
inputs utilized by individual predictors.

Figure 14: Key predictive features used to predict AUC of the 12 disorder predictors. The predictive
performance of individual features is quantified with the Pearson correlation coefficients (PCC) between
feature values (horizontal lines) and the prediction output (actual AUC) for each disorder predictor
(vertical lines) that were quantified on the training dataset. Detailed explanation of features is available
in Appendix 1. PCC values are color-coded where dark green is for |PCC| ≥ 0.3, light green for |PCC|
between 0.15 and 0.30, white for |PCC| < 0.15, and grey with ‘x’ symbol indicate the a given feature is
not included in the model for that predictor. The direction of arrows reveals the sign of PCC where
upwards arrows denote positive correlation while downward arrows denote negative correlation. These
results were published in [140].
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We also analyze importance of the five feature categories that are described in Section 4.2.1 and
which are defined by the data in the sequence profile that was used to produce them. The
importance was quantified with information gain, which measures decrease in the classification
entropy due to the use of a given feature. This is motivated by the use of the entropy in extra‐
tree regressor models [153]. The results for each of the considered 12 disorder predictors are
summarized in Figure 15. The dominant feature category (features extracted from the putative
secondary structure) is consistent for all 12 computational predictors, although the magnitude
of the contribution varies considerably. The predictive value of the secondary structure can be
explained by its relation to the intrinsic disorder. The disorder is poorly predicted in the proteins
with higher fractions of the secondary structures (helices and strands) given that these proteins
are primarily structured. On the other hand, disorder in the proteins heavily composed of coils is
in general well predicted. Moreover, putative secondary structure is also used as the predictive
input by some of the considered here disorder predictors, such as MFDp2 [129], CSpritz [64] and
Spritz [154]. The second and third-best categories of features are the physiochemical properties
and AA composition. They are closely related as both are extracted directly from the protein
sequence. This reveals an implicit bias of the disorder predictors for which performance depends
on the amino acid composition and physiochemical characteristics of the protein. The two leastcontributing feature categories are the sequence complexity and solvent accessibility.
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Importance of feature categories

Predicted secondary structure
Sequence complexity

0.7

Physiochemical properties
Predicted solvent accesibility

Amino acid composition

0.6
0.5
0.4
0.3
0.2
0.1
0

Disorder predictor
Figure 15: Importance the five feature categories for the predictive models designed for the 12 disorder
predictors. We used a three-step process to derive the scores for each predictive model. First, the
information gain of individual features was calculated from the extra-tree regressors. Second, features
were divided into the five classes and the information gain of the features in the same category was
summed up. Third, the summed values were dived by the sum of the information gain values of all features
in the same model. The last step allow for directly comparison of relative contributions of each feature
category. These results were published in [140].

To summarize, the ability of the regressors to predict AUCs of the 12 disorder predictors primarily
depends on the information extracted from the predicted secondary structure, physicochemical
properties and amino acid composition of the input protein sequence. Furthermore, the
predictive quality of specific disorder predictors is governed by unique set of relations, which is
why it is necessary to build and optimize regressors individually for each disorder predictor.

4.3 Assessment of the protein-level disorder predictor recommendation system
4.3.1

Predictive performance of the extra tree regressor models

The regressors that were trained and optimized on the training set of 5,272 proteins were next
comparatively evaluated on the dissimilar test set of 999 test proteins. We note that the training
and test proteins share <25% sequence similarity. The predictive performance of our models is
compared to two controls. We note that this is the first-of-its-kind model that predicts
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performance of disorder predictors and so we are unable to compare it with the prior published
solutions. The first control is a predictor that selects at random an AUC value from the training
dataset. This ensures that this predictor generated the correct distribution of the AUC values for
a given disorder predictor. The second control is based on sequence alignment/similarity. For a
given test protein we use the AUC of the most similar training protein that is selected using the
popular BLAST algorithm with default parameters [155, 156].
The predictive performance is quantified with two metrics: (a) mean squared error (MSE) of
predicted AUCs (when compared with the native/true AUC) and (b) correlation between the
actual ROC-AUC and the predicted ROC-AUC. We use the better of the two controls to calculate
the ratio of improvement between our model and controls.
Table 6: Predictive performance of the extra tree regressor-based model and two controls. Mean squared
error (MSE) and Pearson correlation coefficients (PCC) values are calculated between the predicted AUC
and the actual AUC for each test proteins. Controls were produced using a random and a sequence
similarity-based approaches. Paired significance tests were performed between the predicted AUCs of our
regressor and the results produced by the controls: [+] denotes that our model is significantly better with
p‐value <.05. We used the paired t test for normal measurements and the Wilcoxon test otherwise;
normality was tested with the Anderson‐Darling test at the .05 significance. These results were published
in [140].
MSE (mean squared error)
PCC (Pearson correlation coefficient)
SimilaritySimilarityDisorder predictor
Improvement
Random
Improvement
Extra tree regressor Random control based
Extra tree regressor
based
ratio
control
ratio
control
control
disEMBL-HL
0.009
0.05 [+]
0.05 [+]
5.6
0.36
0.01 [+] 0.13 [+]
2.8
IUPred-long
0.011
0.05 [+]
0.04 [+]
3.6
0.32
-0.01 [+] 0.18 [+]
1.8
IUPred-short
0.011
0.05 [+]
0.05 [+]
4.6
0.32
0.03 [+] 0.07 [+]
4.6
VSL2B
0.008
0.05 [+]
0.05 [+]
6.3
0.31
0.03 [+] 0.14 [+]
2.2
disEMBL-465
0.008
0.05 [+]
0.05 [+]
6.3
0.30
-0.03 [+] 0.14 [+]
2.1
GlobPlot
0.011
0.05 [+]
0.05 [+]
4.6
0.28
-0.13 [+] 0.09 [+]
3.1
ESpritz-NMR
0.009
0.05 [+]
0.05 [+]
5.6
0.28
0.02 [+] 0.08 [+]
3.5
SPOT-Disorder
0.010
0.05 [+]
0.04 [+]
4.0
0.24
0.00 [+] 0.00 [+]
48.0
DISOPRED3
0.004
0.04 [+]
0.05 [+]
12.5
0.24
-0.11 [+] 0.15 [+]
1.6
ESpritz-Xray
0.007
0.05 [+]
0.05 [+]
7.1
0.23
-0.08 [+] 0.03 [+]
7.7
JRONN
0.008
0.05 [+]
0.06 [+]
7.5
0.19
-0.01 [+] 0.00 [+]
190.0
ESpritz-DisProt
0.007
0.05 [+]
0.04 [+]
5.7
0.12
0.00 [+] 0.05 [+]
2.4

Table 6 summarizes the results and reveals that our extra tree regressor model significantly
outperforms both controls in terms of both MSE and PCC (p‐value < .05). While the MSE and PCC
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values of our predictor are modest (PCC at around 0.3 and MSE at about 0.01), we note that the
rate of improvement over the controls is relatively high. The MSE values are between 3.6 and
12.5 folds better than the best control, while correlation values are between 1.6 and 190 folds
better than the controls.
4.3.2

Use of the extra tree regressors for the selection of well-predicted proteins

The extra tree regressors aim to identify proteins that can be predicted with higher predictive
performance for each of the 12 disorder predictors. This will allow the end users and designers
of the future predictors to identify poorly vs. well predicted proteins for a given disorder
predictor. Figure 16 investigates whether our regressors can be used for this purpose. First, for
each disorder predictor, we sort the test proteins in the ascending order of their regressorpredicted AUCs. Then we progressively remove the 5% of proteins with the lowest predicted
AUCs and we calculate the actual AUCs of these protein sets. Figure 16 plots the relation between
the predicted and the actual AUC values of these proteins sets.
The raising trends in Figure 16 demonstrate that the selection done based on the predicted AUC
aligns with the actual predictive performance. The upwards trends are consistent across all 12
disorder predictors. The differences in the actual AUC values between the results on the entire
test dataset (left‐most points in Figure 16) and the smallest set of the 5% of proteins with the
highest estimated AUCs are very substantial. As an example, for DISOPRED3, the 5% of proteins
with the best estimated AUCs secure AUC = 0.950 when compared to AUC = 0.918 on the test
datasets, which translates to (0.950–0.918)/(1–0.918) = 39% error reduction. The largest
absolute increase in AUC is for disEMBL‐HL where the 5% of the best predicted proteins secure
AUC = 0.896 compared to the AUC = 0.761 on the whole test dataset, which corresponds to
(0.896–0.761)/(1–0.761) = 56% error reduction.
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Figure 16: The dataset‐level actual AUC values for subsets of the test proteins that are sorted based on
their AUCs values estimated by the extra tree regressors. Individual panels correspond to different
disorder predictors. Points in each panel correspond to AUCs of the subsets of test proteins for which the
estimated AUCs are above a given percentile of all estimated AUCs, that is, the 20 mark on the x‐axis
corresponds to the 80% of the test proteins that have estimated AUCs that are above the 20th percentile
of estimated AUCs generated by the extra tree regressors. The left‐most point corresponds to the result
on the complete test dataset while the right‐most point corresponds to the 5% of test proteins with the
highest estimated AUCs. The line is the third‐degree polynomial fit into the measured data. These results
were published in [140].
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Figure 17 summarizes the differences in the actual predictive performance measured using
several metrics across the 12 disorder predictors. It shows PR-AUC, sensitivity, MCC and accuracy
in addition to the ROC-AUC. The boxes in the Figure 17 represent the distribution of improvement
for the given evaluation criteria over the 12 disorder predictors. The improvements are measured
by comparing the results on the whole dataset with the results for the three quartiles of selected
proteins according to the predicted AUC (75%, 50% and 25%). Positive values indicate
improvements. The Figure demonstrates that the improvements are always positive, substantial
and consistent for all evaluation criteria. Overall, we conclude that our regressors can be used
to accurately predict the well performing proteins for a given disorder predictor.
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Figure 17: Improvements in the actual ROC-AUC, PR-AUC, sensitivity, MCC and accuracy values computed as the difference between the values
for subsets of the top 25% (in green), 50% (in orange) and 75% (in blue) of the test proteins selected based on their AUCs values estimated by
extra tree regressors and the whole dataset-level AUCs. Positive values of the improvement indicate that AUC for the subsets of the test proteins
are higher than for the complete test dataset. The box plots represent the distribution of the improvements across the 12 disorder predictors
where whiskers corresponding to the minimal and maximal improvements and boxes denote the first, second and third quartiles. These results
were published in [140].
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4.3.3

Predictive quality of DISOselect

This section investigates the performance of the complete recommendation system, DISOselect.
We compare the results produced by the predictors recommended by DISOselect with the results
of the original disorder predictors used individually. We also compare with conventional meta
approaches to combining disorder predictions, where several prediction methods are combined
to give a single prediction, usually at the residue level. We consider several residue-level metaprediction methods based on the 12 individual disorder predictors examined in this work. We
use several variations on the meta-predictor construction: two-different architectures – logistic
regression (LR) and support-vector regression (SVR), and different input predictors – either all 12
predictors or only the best of the predictors. The best predictors were selected based on the
dataset level performance on the training set. Based on these assessments, we selected two
prediction methods – SPOT Disorder and Disopred3 – as significantly better than the other
individual methods. This gave four meta-predictors: Twelve Predictor LR, Twelve Predictor SVR,
Top Two Predictor LR, and Top Two Predictor SVR. The logistic regression model was trained with
the 3-fold cross validation on the training dataset with default L2 regularization penalty by
balanced class weights according to the proportions of training set using the L-BFSG optimization
algorithm. The SVR models were trained with the 3-fold cross validation on the training dataset
after subsampling 10% of each fold randomly to minimize the training time. We used the radial
basis function kernel and performed a grid search for the penalty parameter C (2-5 to 25), kernel
coefficient gamma (0 to 1), and tolerance for stopping criteria (10-3 to 103).
Figure 18 illustrates the protein level ROC-AUC values of DISOselect on the test set (in dark black
thick line) against other 12 individual computational disorder predictors and the two best
conventional meta-predictors (thick blue line and thick yellow line). The dark red line denotes a
hypothetical oracle predictor which always picks the best performing disorder predictor for each
given individual protein. Figure 18 shows that DISOselect performs substantially better than all
individual disorder predictors and the conventional consensus approaches. Moreover, the
DISOselect’s performance is relatively close to the hypothetical best possible approach (oracle
predictor).
59 | P a g e

Figure 18: Comparison of the per-protein AUC values between the 12 disorder predictors, the selection
of the best disorder predictor using the highest putative AUCs generated by DISOselect (thick black line),
and the oracle method (thick red line), and two conventional meta predictors (thick yellow and blue lines)
on the test proteins. The oracle method selects the disorder predictor with the highest AUC among the
12 disorder predictors. Lines show the per-protein AUCs that are sorted in the ascending order for each
of the considered methods. These results were published in [140].

Table 7 directly compares the performance of the considered models. It compares the mean of
per protein ROC-AUC values produced by DISOselect, the twelve individual disorder predictors,
and the oracle approach. Statistical tests of significance reveal that DISOselect generates the perprotein ROC-AUC values that are significantly better than the results offered by each of the 12
disorder predictors (p-value < 0.01). The oracle predictor gives the per protein mean ROC-AUC of
0.98 while DISOselect has ROC-AUC = 0.97.
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Table 7: Comparison of the per-protein AUC values produced by the 12 disorder predictors, the oracle
method that selects the predictor with the highest AUC and the selection based on the highest putative
AUC produced by DISOselect for the test proteins. We compared the mean per-protein AUCs computed
over the test proteins and the AUCs for the worst (the least accurately predicted) quartile of the test
proteins (i.e., the 25% point in Figure 17). Methods are sorted by their mean per-protein AUCs.
Significance of the differences in the per-protein AUCs of the predictions selected by DISOselect and the
predictions generated by the other methods (including the oracle) was assessed with the t-test for normal
measurements and the Wilcoxon test otherwise; normality was tested with the Anderson-Darling test at
0.05 significance; we sampled 50% of proteins in the test dataset ten times at random and compared the
corresponding 10 pairs of AUCs; the resulting p-values are listed in the last column. These results were
published in [140].
Predictor
Oracle
DISOselect
SPOT-Disorder
DISOPRED3
ESpritz-Xray
ESpritz-NMR
VSL2B
disEMBL-465
IUPred-short
disEMBL-HL
ESpritz-DisProt
JRONN
IUPred-long
GlobPlot

Mean perprotein AUC
0.983
0.974
0.940
0.935
0.880
0.865
0.864
0.853
0.843
0.816
0.772
0.733
0.718
0.646

Per-protein AUC at the worst
quartile of proteins
0.984
0.971
0.927
0.921
0.832
0.809
0.816
0.768
0.768
0.719
0.649
0.603
0.584
0.537

Significance of differences
compared to DISOselect
p-value<0.01 (significantly better)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)
p-value<0.01 (significantly worse)

The analysis in Figure 18 is aggregated at the test dataset level for clarity, i.e., we compared resorted per-protein AUCs across different methods. Figure 19 offers a direct comparison of
predictive performance of the results selected with DISOselect against the most accurate
individual disorder predictor (SPOT-Disorder), the best performing meta-prediction method (Top
Two Predictor SVR), and an average disorder predictor. When compared against SPOT‐Disorder
(red line), DISOselect selects a better disorder prediction for 64% of proteins, the same prediction
for 5% of proteins, and worse prediction for 31% of proteins and has average overall
improvement of 0.035. DISOselect is better for 64% of proteins, equal for 4% of proteins and
performs worse for 34% proteins when compared to the best conventional consensus method
(green line). Finally, DISOselect performs better than average of the 12 computational disorder
predictors for 95% of proteins with overall average improvement of 0.152.
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Figure 19: Evaluation of the differences in the protein‐level area under the receiver operating
characteristic curves (AUCs) for the same test proteins between the predictions selected with DISOselect
and the average AUC of the 12 disorder predictors (blue line), between the predictions selected with
DISOselect and the predictions generated by the most accurate disorder predictor at the dataset level,
SPOT‐Disorder (red line), and between the predictions selected with DISOselect and the best consensus‐
based method that relies on the support vector regression (SVR) (green line). Points indicate where the
difference between protein AUCs crosses zero. The proteins are sorted by the value of the difference in
the descending order. These results were published in [140].

4.4 DISOselect webserver
We developed and released a webserver that implements DISOselect as a free service for noncommercial users. This webserver is available at http://biomine.cs.vcu.edu/servers/DISOselect/.
DISOselect requires only the FASTA-formatted protein sequences as input. Up to 1000 proteins
can be predicted in a single run. All computations are performed on the webserver side. The
webserver outputs the putative AUC and the qualitative performance (including the percentile
of predicted AUC value) for each of the 12 disorder predictors, which are sorted in the descending
order of the predicted AUC. The predictor at the top of the list, which has the highest estimated
AUC, is recommended to the user as the best option to collect the disorder predictions. For the
user’s convenience, the main page of the webserver provides links to the websites of these
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disorder predictors under the “Help” section. The results are available via an HTML page, which
can be accessed via a direct link, and a parsable text file. We will archive these results for at least
one month.

4.5 Summary
Our empirical analysis shows that the per-protein predictive quality of popular disorder
predictors varies widely between different proteins. The users cannot expect that the disorder
predictor with the best benchmark-dataset level results will provide favorable results across all
proteins. These results suggest that a computational tool that can accurately estimate perprotein predictive performance for a given disorder predictor and a given protein is needed.
To this end, we developed a new recommendation system, DISOselect, which accurately
identifies well-predicted proteins for each of the 12 considered disorder predictors and which
recommends the best performing disorder predictor for a given input protein. We analyze these
two capabilities from several different perspectives and we show that DISOselect outperforms
the currently available solutions. More specifically, the disorder predictions selected using
DISOselect are significantly more accurate than the results produced by any of the 12 disorder
predictors, including the top‐performing methods such as SPOT‐Disorder and DISOPRED3, and a
selection of four conventional consensus predictors. The average per‐protein AUC for the
predictions selected with DISOselect is 0.97, compared to an average AUC of 0.82 generated by
the 12 methods, and an average AUC of 0.94 for the consensus methods.
DISOselect provides two key advantages to the end users. First, it offers advice on whether a
given disorder predictor would provide an accurate prediction for a given protein of user’s
interest. Second, if users are comfortable with using multiple disorder predictors, DISOselect
accurately recommends the most suitable predictor. Importantly, besides suggesting the best
tool, DISOselect informs the users about the expected predictive quality of this selected and
other disorder predictors. This fast-to-compute insight is provided before the user has to actually
make the possibly time-consuming disorder prediction.
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Chapter 5. Assessment and comparative analysis of the predictive
performance of disorder predictions for specific functional types of
disordered proteins
Protein functions and structures can be classified using a wide range of resources, which include
Pfam [157], SCOP [158], SUPERFAMILY [159], and CATCH [160]. Along those same lines, IDPs are
classified based on different criteria, such as function [5, 25, 34, 161, 162], functional motifs
[163], and sequence features [164, 165]. This chapter addresses objective 3, which aims to
compare predictive performance of disorder predictions for specific functional types of IDPs.
These results were published in [166].
As we discuss in Chapter 3, the predictive performance of disorder predictors was empirically
assessed in numerous comparative studies [68-78]. The results of these studies, which were
surveyed in Chapter 3 (at the protein level) and a recent article (at the dataset level) [14], can be
used to perform side-by-side comparisons of the predictive performance of the disorder
predictors. They can be used to guide the users to select accurate predictors and to inform the
both users and developers about the current levels of predictive quality offered by the best tools.
The latter fuels the progress in the development of gradually more accurate tools. This progress
was recently summarized in [23], where the authors show that the predictive performance
measured with AUC (Area Under the ROC Curve) have risen from the 0.73 to 0.79 range in mid
2000s, to the 0.85 to 0.90 range that is secured by the methods that were published in the last
four years. While the past comparative studies provide invaluable insights, they also share a few
drawbacks. First, they perform the assessment using generic sets of proteins while they rarely
(only once) analyzed performance for specific functional protein families. Second, they overlook
an important aspect of the similarity between the benchmark dataset and the training datasets
that were used to develop the tested predictors. High levels of similarity may result in an
overestimation of the predictive performance and may distort the results by favoring certain
methods for which the similarity is higher. Third, some of the previous assessments assume that
non-disordered regions from the proteins that are collected from DisProt database are structured
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while some of these regions bear the possibility of being disordered. To this end, we performed
the first-of-its-kind comparative analysis that includes analysis of the performance for several key
functional types of disordered proteins (protein- and nucleic acid-binding proteins [167-170]),
that develops and utilizes a new benchmark dataset that ensures controlled/low levels of
similarity with the training datasets of the assessed predictors with validated structured regions.

5.1 Overview of the past intrinsic disorder predictor assessments
We start our assessment by providing a detailed overview of previous surveys of the intrinsic
disorder predictors. We identified a total number of 28 surveys regarding intrinsic disorder
predictors that were published during the period from 2003 to 2020 in peer reviewed venues
[14, 68-78, 171-186]. The conventional format used in the above surveys is to start with a
historical background of disorder predictor development and subsequently contrast the designs
of different methods, including their input features and predictive models. In some of the
surveys, selected disorder predictors were compared based on their predictive performance.
The first reported survey on disorder predictors was published in 2003 as part of the CASP5 [68]
(Critical Assessment of Structure Prediction), which is 5th edition of the biannual assessment of
the protein structure predictions. We summarize the abovementioned 28 surveys in the figure
20 based on their date of publication and categorize them into to three groups considering the
intended target of the assessment. The respective categories include the assessments of disorder
predictors, assessments of the disorder function predictors and assessments that consider both
disorder predictors and disorder function predictors. The recent surveys put more emphasis
towards assessing the disorder function predictors over the disorder predictors. Functions of IDRs
are classified based on their cellular function and the interaction partners [187-189]. Recent
study reveals that protein binding and nucleic acids binding collectively account for 84% of
available molecular partner annotations in the DisProt for IDR [171]s. The specific fractions of
available molecular partner annotations in the DisProt for IDRs with different interaction partners
are as follows. Protein binding accounts for 66% of available molecular partner annotations while
nucleic acid binding, metals, lipids, small molecules and inorganic salts respectively account for
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17%, 6%, 5% ,5% and 1%. These fractions justify our focus on the protein binding and nucleic acid
binding IDRs in this assessment.

Figure 20: Chronological summary of the past surveys of the intrinsic disorder and intrinsic disorder
function predictors. This figure was published in [166].

Out of the 28 surveys, 11 have conducted comparative assessments to compare the predictive
performance between multiple disorder and disorder function predictors. We further analyze the
above mentioned 11 surveys in Table 8 to assess their impact and scope. Majority of the above
surveys accumulated over 100 citations according to Google Scholar, suggesting that they have
attracted substantial amount of interest. These 11 surveys include six editions of CASP from
CASP5 (2002) to CASP10 (2012) [68, 73, 75-78]. The disorder assessment category was
discontinued from the CASP series after 2012 with the intention of initiating a separate dedicated
community driven assessment for intrinsic disorder.
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Table 8: Summary of the past comparative assessments of disorder predictors. The articles are sorted chronologically (from the most recent). The
citation numbers were collected from Google Scholar on September 29, 2020. Predictors shown in the bold font in the “suggested best disorder
predictors” column are included in the comparative assessment in this section. This table was published in [165].
Benchmark
Year most recent Number
dataset has
Year
assessed
reduced similarity
of
assessment
citations with training sets
predictor
published
of the assessed
published
predictors

Article Target of assessment

Suggested best disorder predictors (year
published)

disordered proteins; disordered
this
protein-binding protein; disordered
article
nucleic acids-binding proteins

N/A

N/A

2018

N/A

yes

[69]

disordered proteins

SPOT-Disorder (2017), DISOPRED3 (2015)

2019

2017

4

no

[70]

disordered proteins

Espritz (2012)

2018

2017

33

no

[71]

disordered proteins

DisEMBL (2003), IUPred (2005)

2015

2012

121

no

[73]

disordered proteins

DISOPRED3 (2015), PrDOS (2007), MFDp (2010)

2014

2015

128

no

[72]

disordered integral membrane
proteins

PreDisorder (2009)

2014

2012

12

no

[74]

disordered proteins

MFDp (2010), MD (2009), PONDR-FIT (2010)

2012

2010

149

no

[75]

disordered proteins

PrDOS (2007), DISOPRED (2004)

2011

2010

118

no

[76]

disordered proteins

GS‐MetaServer (2012), PreDisorder (2009)

2009

2008

131

no

[77]

disordered proteins

DISOPRED (2004), DISpro (2005)

2007

2006

109

no

[78]
[68]

disordered proteins
disordered proteins

predictor by Obradovic et al.
N/A

2005
2003

2004
2002

114
97

no
no
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Table 8 reveals that depending on the assessment, the set of the disorder predictors that are
indicated to provide the best predictive performance differs. This inconsistency is partly due to
the fact that these articles consider different sets of disorder predictors in the assessments.
However, majority of the surveys suggested that the best disorder predictors are among the most
recently published methods, respective to the time when the survey was conducted. As an
example, the latest comparative survey that was published in 2019 [69] indicates that SPOTDisorder [190] and DISOPRED3 [191] as best disorder predictors while SPOT-Disorder was
commissioned after nine out of 11 surveys were published. The latest three surveys [69-71], at
the time when this work was published in 2020 [166], indicate that SPOT-Disorder [190],
DISOPRED3 [191], ESpritz [192], DisEMBL [54] and IUPred [193-195] as the highest performing
disorder predictors.
According to Table 8, when it comes to the intended target of the assessment, 10 surveys assess
the disorder predictions for a generic set of proteins while one [72] assesses the disorder
predictions for the disordered integral membrane proteins. The latter survey compares the
predictive performance among 13 disorder predictors using a dataset that consists of around 350
membrane proteins. Potential reason for the fact that none of the past survey focused on the
disorder function predictors could be the limited number of available experimental annotation
for the disorder functions. The disorder binding partner annotations were added to the DisProt
database in 2016 and in limited quantities. They were further extended from the original list of
1108 IDRs to 1476 IDRs only in 2020 in the new release of DisProt.
We discuss another important aspect of disorder predictor assessments in the last column of
Table 8 where we consider the sequence similarity of the test data they use with respect to the
training datasets of the predictors that they asses. None of the 11 assessments take measures to
limit the sequence similarity of the benchmark dataset against the training datasets. As an
example, the CASP assessments [68, 73, 75-78] create their benchmark datasets using unreleased
PDB structures at the time of the assessment and disregard the similarity to the training datasets
of the considered predictors. Other recent surveys collect their benchmark proteins from
MobiDB, DisProt and UniProt databases without limiting the sequence similarity to the training
datasets of the assessed predictors [69-71]. Interestingly, the process of training and
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validation/testing of new disorder predictors ensures that the sequence similarity of the test
dataset against the training datasets is intentionally reduced, at least for the methods that is
being proposed. The usual practice is to limit the sequence similarity between test dataset and
training dataset below 30% [62, 196-200]. Limiting the sequence similarity of the test dataset is
meant to demonstrate that a given method can solve the non-trivial problem of predicting
dissimilar sequences. This is because a simple sequence alignment is capable of making strong
predictions in the presence of high similarity.
Altogether, we show that past surveys share several drawbacks. They do not consider evaluating
disorder predictions for specific disorder functions (except for one survey that focuses on
membrane proteins) and fail to properly control sequence similarity of their test dataset to the
training datasets of the tested methods. We address these aspects in our subsequently described
survey.

5.2 Selection of disorder predictors
We cover a comprehensive set of 10 disorder predictors. The selection of these predictors was
motivated by their availability, availability of their training datasets, computational efficiency and
previously reported predictive performance. The selected computational disorder predictors
cover all three types of prediction architecture classes that were described in the Section 2.2.1.
The analysis includes GlobPlot [47], IUPred-short and IUPred-long [48] representing the ab initio
methods. DisEMBL, VSL2B [53], SPOT-Disorder [100] that are the machine learning methods.
Finally, DISOPRED3 [112] and the three versions of ESpritz that are tuned to predict intrinsic
disorder annotated from X-ray structures (ESpritz-Xray), NMR structures (ESpritz-NMR) and using
DisProt database (ESpritz-DisProt) [192] represents the meta predictors. These predictors are
highly-cited and by extension often used. Their citation numbers are 1763 (IUPred), 1241
(DisEMBL), 1002 (GlobPlot), 680 (VSL2B), 355 (DISOPRED3), 256 (ESpritz), and 107 (SPOTDisorder); source: Google Scholar on April 14, 2020. Moreover, this selection of methods overlaps
with the predictors that were covered in the recent comparative assessments [69-71] and
includes the five tools (SPOT-Disorder, DISOPRED3, DisEMBL, IUPred and ESpritz) that have been
highlighted as the best-performing in the last three comparative surveys [69-71].
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5.3 Collection of benchmark dataset
According to a recent analysis, the two most commonly annotated partners of IDPs are proteins
and nucleic acids, which collectively cover 84% of the partner-annotated disordered regions in
the DisProt resource [171]. More precisely, 66% partner-annotated regions have protein
partners, 17% nucleic acids partners, 6% metals, 5% lipids, 5% small molecules, and 1% inorganic
salt partners. This motivates our focus on the protein- and nucleic acids-binding IDPs.
Recent comprehensive survey concludes that an “updated and more comprehensive benchmark
datasets should be established” [14]. Correspondingly, we establish a new benchmark set with
two main objectives in mind: 1) explicit reduction in similarity to the training sets of the selected
10 disorder predictors; and 2) inclusion of the annotations of the protein-binding and nucleicacid binding proteins. First, we collected the complete set of 1,418 proteins from the newest
version 8 of DisProt that have experimental annotations of disorder and binding partners; we
exclude the annotations marked as “ambiguous” in DisProt. Second, we collected the training
datasets of the ten disorder predictors. We clustered the combined set of the DisProt and training
proteins using CD-Hit [201] at 30% sequence similarity and we removed all clusters that include
at least one training protein. The remaining set of 319 DisProt proteins is dissimilar to the training
proteins (at 30%) and includes functional annotations that allow us to identify the sets of proteinbinding proteins (that include at least one disordered protein-binding region) and nucleic-acid
binding proteins (that include at least one disordered nucleic acid-binding region). Third, we
mapped the un annotated regions from DisProt protein sequences into PDB. In order to execute
this mapping, we first create a database of PDB sequences where regions that lack structure are
masked. Then we align unannotated regions from Disprot protein sequences to above masked
PDB sequence database using BLAST. We annotate any unannotated DisProt protein region which
aligns to at least one masked PDB sequence region with ≥ 90% similarity and have e-value ≤ 0.1
as structured. In order to do generate a more diverse and balanced dataset we match the number
of fully disordered proteins (38) in the dataset with equal number of fully structured proteins
from PDB. When we are selecting fully structured sequences from PDB we make sure to minimize
the risk of them including any disordered regions by selecting monomers with high-quality crystal
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structures (resolution < 2Å) that cover complete UniProt sequences based on mapping with SIFTS
[202]. We cluster abovementioned fully structured protein sequences from PDB with the training
datasets of selected disorder predictors using CD-HIT at 30% sequence similarity threshold and
select 38 random proteins which do not belong to clusters with protein sequences from training
datasets of selected disorder predictors. The final dataset consists of total number of 357
proteins that has experimental disorder and disorder function annotations from Disprot,
validated structured region annotation from PDB and unmapped regions where they are
excluded from the assessment. This benchmark dataset is summarized in Table 9. We emphasize
that this dataset not only ensures low similarity to the training datasets of the tested methods
but also uses high-quality annotations of the structured regions and includes fully structured
proteins. This allows us to accurately study performance of the disorder predictors on the
structured proteins and regions, which is another important feature that is missing in the past
surveys.
Table 9: Summary of the benchmark dataset. This table was published in [165].
Metric
Number of proteins
Number of residues
Number of disordered residues
Disorder content (% of disordered residues)

Complete
dataset
357
186,337
31,608
0.17

Protein-binding
proteins
108
38,221
14,125
0.37

Nucleic acidsbinding proteins
15
5,934
1,567
0.26

5.4 Comparative assessment of predictive performance
5.4.1

Effect of the sequence similarity reduction and structured region validation on benchmark
dataset

In this section we assess the impact of the sequence similarity reduction and structured region
validation of the benchmark dataset to the predictive performance of selected 10 disorder
predictors. As an initial point of reference, we report the predictive performance of same 10
disorder predictors from previously conducted surveys. The previously reported predictive
performance nine of the ten predictors was taken for from [70] and for the remaining SPOT71 | P a g e

Disorder from [203]. The previous evaluations do not limit the similarity of benchmark dataset
against the training datasets of the respective disorder predictors as well as do not validate the
experimental annotations for the unannotated regions in the DisProt proteins. In Figure 21, we
denote the results from previous surveys as “previous results” using the black line. We also report
results for two versions of our new benchmark dataset. One with limited similarity to the training
datasets of the tested predictors (but without validation of the experimental annotations of
order, like it was done in the past surveys) and in the other version we limit the similarity to the
training datasets and validate the experimental annotations of unannotated regions in the
DisProt proteins. The results for the methods in the first version are denoted as the “limited
similarity benchmark” in Figure 21 and shown using the red line. The predictive performance for
the second version of dataset with limited similarity and ordered region validation is denoted as
the “new benchmark” and shown using green lines.

Figure 21: Comparison of the predictive quality measured with AUC (panel A; solid lines) and MCC (panel
B; dashed lines). We report results on the new benchmark (in green; dataset with <30% sequence
similarity to the training proteins + with experimental validation of structured regions + with fully
structured proteins), based on recent previous reports (in black; datasets with no limits on sequence
similarity to the training proteins + with no experimental validation of structured regions + with only
disordered proteins), and based on a similarity-limited benchmark (in red; a version of the new benchmark
dataset with <30% sequence similarity to the training proteins + no experimental validation of structured
regions + only disordered proteins). The latter dataset is a proxy for the datasets used in prior studies with
the only difference being the reduced similarity to the training proteins. Disorder predictors are sorted by
their AUC values on the new benchmark dataset. This figure was published in [165].
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The analysis of the differences in the predictive performance between the “previous results”
(black lines in Figure 21) and the “limited similarity benchmark” (red lines in Figure 21) allows us
to assess the effect of limiting sequence similarity against the training datasets of the selected
disorder predictors. These results are highly correlated with Pearson’s correlation coefficient of
0.94 for ROC-AUC and 0.89 for MCC. Moreover, we note a consistent drop in the predictive
performance across the 10 considered predictors from the “previous results” to the “limited
similarity benchmark” results in both ROC-AUC and MCC. The average ROC-AUC across all 10
considered predictors drops by 0.03 (0.72 vs 0.75). The average MCC drops by 0.06 (0.03 vs 0.36).
Furthermore, the best methods based on the two predictive performance measures also record
a drop in the predictive performance with the sequence similarity reduction. ESpritz-DisProt
which records the highest AUC in the past survey drops by 0.05 (from 0.804 to 0.758) and SPOTDisorder which records the highest MCC in the past survey drops by 0.10 (from 0.462 to 0.361)
These observations demonstrate that results on the benchmark datasets that share high
sequence similarity with the training datasets of the predictors that they asses tend to
consistently inflate the predictive performance.
The predictive performance difference of methods between the “limited similarity benchmark”
and the “new benchmark” experiments demonstrate the impact of providing experimental
validation to the unannotated regions in the DisProt proteins. We observe that the predictive
performance improves when using the validated experimental annotations of the ordered
regions. According to Figure 21, the highest improvement is for VSL2B which improves ROC-AUC
by 0.14 and MCC by 0.20. In contrast, the overall poorly performing GlobPlot drops its predictive
performance when using the experimentally validated order annotations. GlobPlot is originally
designed to differentiate globular proteins from non-globular proteins, where the lack of
“globularity” acts as a proxy to detect disorder. We show that GlobPlot detects validated
structured regions as non-globular while they are in fact not disordered (and not necessarily
globular).
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Table 10: Predictive performance on the new benchmark dataset. The table lists results on the complete benchmark dataset with 357 proteins,
the set of 38 fully disordered proteins, the set of 38 fully structured proteins, and the benchmark dataset of 319 proteins that exclude the fully
structured proteins. We quantify statistical significance of differences in AUC between the best predictor (identified in bold font) and each the
other nine predictors on a given dataset. We bootstrap 50% of the proteins 100 times. For normal measurements (tested with the AndersonDarling test at 0.05 significance) we use the paired t-test; otherwise we use the Wilcoxon rank sum test; = and + mean that the differences are not
significant (p-value > 0.01) and significant (p-value ≤ 0.01), respectively. This table was published in [165].

Predictor
VSL2B
ESpritz-DisProt
SPOT-Disorder
ESpritz-Xray
IUPred-short
IUPred-long
ESpritz-NMR
DISOPRED3
DisEMBL
GlobPlot
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Benchmark dataset
AUC
0.897
0.858+
0.795+
0.790+
0.788+
0.785+
0.743+
0.724+
0.717+
0.310+

Precision Sensitivity FPR
0.609
0.845
0.204
0.593
0.487
0.060
0.334
0.756
0.261
0.375
0.623
0.193
0.431
0.613
0.170
0.422
0.693
0.233
0.336
0.721
0.310
0.294
0.653
0.293
0.308
0.439
0.162
0.122
0.428
0.655

MCC
0.519
0.473
0.390
0.366
0.386
0.373
0.317
0.283
0.257
-0.175

Fully disordered Fully ordered
Benchmark dataset without fully ordered proteins
proteins
proteins
Sensitivity
FPR
AUC
Precision Sensitivity
FPR
MCC
0.925
0.000
0.805+
0.611
0.845
0.399
0.404
0.811
0.052
0.842
0.685
0.487
0.067
0.486
0.662
0.290
0.826+
0.578
0.756
0.234
0.485
0.702
0.226
0.812+
0.586
0.623
0.160
0.459
0.692
0.176
0.801+
0.607
0.613
0.165
0.444
0.834
0.262
0.806+
0.625
0.693
0.206
0.463
0.774
0.351
0.776+
0.563
0.721
0.272
0.414
0.662
0.340
0.767+
0.513
0.653
0.248
0.380
0.559
0.193
0.741+
0.520
0.439
0.132
0.336
0.388
1.000
0.563+
0.332
0.428
0.326
0.096

5.4.2

Comparative assessment of disorder predictors on the benchmark dataset

In Table 10 we compare the predictive performance of the ten disorder predictors. The left panel
gives the results for the full benchmark dataset with 357 proteins. VSL2B predictor records the
highest ROC-AUC of 0.89 which it is significantly better than other 9 predictors (p-value <0.01).
At the same time several other disorder predictors record high predictive performance
(AUC>0.75 and MCC>0.35) on this benchmark dataset including ESpritz-DisProt, SPOT-Disorder,
ESpritz-Xray and both versions of IUPred. Precision measures of the VSL2B and ESpritz-DisProt
reveal that these methods identify majority of the disordered residues correctly. Moreover,
VSL2B and SPOT-Disorder record the top two sensitivity values indicating they identify over 75%
of the native disorder residues. These results reveal that several disorder predictors are capable
of providing accurate predictions.
The right panel of Table 10 reports the predictive performance of the ten selected methods on a
subset of the complete benchmark dataset where we exclude fully structured proteins. In this
subset ESpritz-DisProt shows the highest predictive performance with ROC-AUC of 0.85 which is
significantly better than other nine methods (p-value <0.01). The sensitivity remains same as the
complete benchmark dataset as the native disordered residues are unchanged. The precision
improves by a large margin for all predictors, except for VLS2B, when the fully ordered proteins
are removed. This is because majority of these methods predict substantial number of false
positives in the fully ordered proteins. This is further validated by the FPR column for the fully
ordered proteins where the considered methods predict between 5% (ESpritz-DisProt) and 100%
(GlobPlot) of the false positive predictions. The one exception is VSL2B that produces no false
positives in these proteins. At the same time, we observe that FPRs for the fully ordered proteins
are in line with FPRs in the subset of the dataset that includes disordered proteins. We find that
nine out of ten methods overpredict disorder in the fully ordered proteins as well as in the
ordered regions of the disordered proteins. The one exception, VSL2B, scores 0.00 FPR in the fully
ordered proteins and highest sensitivity in the fully disordered proteins. This explains VLS2B’s
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overall best predictive performance in our similarity-limited benchmark dataset (Table 10 and
Figure 21).
We conclude that VSL2B is the most versatile method among the ten considered disorder
predictors, particularly when it comes to predicting disorder for the fully ordered and fully
disordered proteins.

Apart from this, ESpritz-DisProt and SPOT-Disorder provide strong

predictive quality measured with the ROC-AUC and MCC scores.
5.4.3

Predictive performance assessment on the disordered protein-binding and nucleic acidbinding proteins

In this section we provide the comparative analysis of predictive performance for the 10 disorder
predictors in two main functional sub-classes of the disordered proteins, namely the disordered
protein-binding proteins and the disordered nucleic acid binding proteins. We compare the
predictive performance of the methods across the above mentioned two functional sub-classes
as well as against the complete benchmark dataset. In order to conduct this comparison, we
equalize the native disorder content among the two sub-classes and the complete benchmark
dataset. The disorder content equalization is motivated by several previous studies that show
that the predictive performance of disorder predictors drops when tested on proteins with larger
amount of the native disorder [17, 59, 69, 126].
We perform disorder content equalization by subsampling the two larger sets (the complete
benchmark dataset and the disordered protein binding subset) to match the disorder content in
the smallest set of the disordered nucleic acid binding proteins. We start the subsampling by
calculating the protein level native disorder content distributions for each dataset and
quantifying the significance of the differences between these distributions. Next, we remove the
proteins from two large subsets that increase the p-value by largest margin until we reach pvalue of 0.001. Figure 22 shows that predictive performance distribution of the 10 methods
before (grey box plots) and after (white box plots) we equalize the native disorder content. Figure
22 shows that even though absolute values of the predictive performances are shifted by
disorder content equalization, the relative differences in the predictive performance across the
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datasets remain similar (i.e., differences between the white box plots follow the same pattern as
the differences for the gray box plots).
A

B

Figure 22: Distribution of the AUCs (panel A) and MCCs (panel B) over nine disorder predictors. We exclude
the poorly‐performing GlobPlot from this analysis. The box plots show the lowest AUC (bottom error bar),
first quartile (bottom of box), median (horizontal line inside box), third quartile (top of box) and highest
AUC (top error bar). The grey plots are for the original datasets while the white plots are for the
sampled/disorder content‐equalized datasets that have similar distribution of the per‐protein disorder
content. The content distribution similarity was measured using Kolmogorov–Smirnov test at p‐value of
0.001. This figure was published in [165].

Figure 23 shows the predictive performance of the ten disorder predictors across two functional
sub-classes of disorder and for the generic disordered proteins in the benchmark dataset. These
results reveal that predictions for the disordered nucleic acid binding proteins secure similar
levels of predictive performance as the performance for generic disordered proteins. The average
(across predictors) ROC-AUC is 0.781 for the nucleic acid binding proteins while it is 0.774 for the
generic disordered proteins. Similarly, the corresponding average MCCs are 0.422 and 0.406,
respectively. At the same time, we observe that quality of the predictions for the disordered
protein binding proteins drops substantially when compared to other two results, with the
average ROC-AUC of 0.739 and average MCC of 0.356. According to Figure 23, this decrease in
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the predictive performance is consistent across eight of the ten predictors. One of the exceptions
is ESpritz-DisProt that maintains similar levels of predictive performance across two functional
sub-classes and the generic disordered proteins. The second exception is GlobPlot that registers
consistently poor predictive performance. The best performing disorder predictor for the generic
disordered proteins and disordered protein binding proteins is ESpritz-DisProt while for the
nucleic acid binding proteins the best results are produced by SPOT-Disorder. These results are
in agreement with a recent study that was conducted using structured/ordered proteins [204]. It
shows that the quality of the predictions of the protein binding residues is much worse that the
quality of the predictions of the DNA/RNA binding protein residues for the structured proteins.

Figure 23: Comparison of the predictive quality measured with AUC (panel A; solid lines) and MCC (panel
B; dashed lines). We report results on the generic set of disordered proteins (i.e., proteins that have
disordered residues) from benchmark dataset (in black), the disordered protein-binding proteins (in
yellow), and the disordered nucleic acids-binding proteins (in blue). Disorder predictors are sorted by their
AUC values on the disordered proteins. This figure was published in [165].

5.5 Summary
Prediction of intrinsic disorder plays an important rule to bridge the large and growing gap
between the limited amount of the available experimental annotations and the large numbers of
newly discovered unannotated protein sequences. Over 60 disorder predictors are currently
available. This large number of tools makes it challenging to identify the best disorder predictor
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for a given set of proteins. One option to solve this problem is to use DISOselect, the tool that we
developed and describe in Chapter 4. Another option is to rely on the disorder predictor
assessments that focus on providing insights that would facilitate selection for specific classes of
the disordered proteins. This would be suitable in scenarios where the end user would know the
class of the disordered proteins that they work with (e.g., whether it bind proteins or nucleic
acids). We identify 11 surveys that provide comparative assessment of predictive performance
[68-78] and observe that only one of them provides analysis for a specific class of disordered
proteins (membrane proteins). To this end, we conduct first-of-its-kind analysis that assesses the
predictive performance for two large functional sub-classes of the disordered proteins: protein
binding and nucleic acid binding proteins. Our analysis also overcomes two other limitations of
the previous studies: use of test datasets that may include proteins that are similar to the training
datasets of the tested predictors and lack of validation for the annotations of the ordered regions.
We consider a representative set of ten disorder predictors and a benchmark set with limited
similarity to the training datasets of these predictors and we use validated experimental
annotations of the ordered regions in that test dataset.
Our assessment reveals that limiting the similarity of the benchmark dataset against the training
datasets of the selected disorder predictors results in a consistent and substantial drop in the
predictive performance when compared with previous assessments that did not limit the
similarity [69-71, 73, 205]. This means that the results of the past studies likely overestimate the
predictive performance.
The proper validation of the experimental annotations of the ordered regions in the disordered
proteins results in higher levels of the reported predictive quality. This is because higher quality
ground truth information is used to quantify the predictive performance. We suggest that future
assessments should take this into consideration when designing benchmark dataset.
We identify three disorder predictors that offer particularly strong predictive performance.
VSL2B is the most versatile method that provides the best results for the fully structured and fully
disordered proteins and very strong results for proteins that have disordered regions. However,
ESpritz-DisProt and SPOT-Disorder outperform VSL2B for the latter type of proteins. Most
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importantly, we analyze performance for the two functional classes of disordered proteins:
protein and nucleic acid binding proteins. We demonstrate that majority of the disorder
predictors offer much lower predictive performance for the disordered proteins with protein
binding regions. The AUC and MCC values for these proteins are on average lower by 0.04 and
0.05 when compared to the set of generic disordered proteins, and by 0.04 and 0.07 when
compared to the disordered nucleic acids-binding proteins, respectively.
These results suggest certain functional classes of disordered proteins are more difficult to
predict accurately, calling for the development of new disorder predictors. At the same time, our
research also shows complete lack of tools to predicts some of the functional classes of the
disordered proteins. While specialized tools for the predictions of the disordered protein and
nucleic acids binding are already available [172, 173, 206], we find that disordered lipid binding
interactions are devoid of predictive tools. This predictive target was neglected primarily because
of the limited availability of reliable experimental annotations. However, with the recently
growing numbers of experimental annotations and rapid advancements in machine learning
techniques that allow building models from limited-size datasets (e.g., deep neural networks
coupled with transfer learning), the development of computational methods to predict these
neglected functions become feasible. The next chapter addresses the development of such new
predictive tool.
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Chapter 6. Accurate prediction of the disordered lipid-binding residues
from protein sequences
6.1 Introduction and motivation
This chapter addresses objective 4 that is defined in Section 1.2. We have conceptualized,
developed and comparatively tested a runtime-efficient computational system that accurately
predicts disordered lipid-binding residues in the intrinsically disordered proteins. IDRs are shown
to have molecular level interactions with multiple binding partners including proteins, DNA, RNA,
lipids, metal ions and other small molecules [34, 167, 168, 207-211]. However, only few hundred
of IDRS are experimentally annotated with their binding partners [34, 206]. These data can be
used to build tools capable of predicting IDR-partner interactions for the majority of the
disordered proteins that currently lack these functional annotations [172, 173, 180, 206, 212].
As we show in Section 2.2.2 (Table 4), significant majority of current computational predictors of
disorder functions aim to predict disordered protein-binding regions. In contrast, there is only
one method, DisoRDPbind [104, 105] for the prediction of the DNA and RNA interactions. To best
of our knowledge, there are no tools that predict disordered lipid-binding regions. The lack of the
computational methods that predict interactions with majority of the binding partners can be
explained by the lack of a sufficient amount of the experimentally annotated data to develop and
validate such predictors. However, recent rapid growth in the amount of the available
experimental annotations for the binding partners has enabled the development of new
computational predictors. As an example, the latest version (version 8.0) of the DisProt, which is
the largest repository of the functional annotations of IDPs, has grown by about 50% in the
amount of the annotations for the disordered lipid binding regions when compared to the
previous version of DisProt (version 7.2) [8, 33].
Lipid molecules carry out many important structural and functional roles including energy
storage, regulation, signaling, insulating and transporting [213-218]. Studies show that lipids
interact with proteins. For instance, lipid molecules facilitate fibrillogenesis by inducing protein
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structures to assemble into protofibrillar and fibrillary structures [219-222]. Conventional
experimental techniques to identify protein-lipid interactions include immunocytochemistry,
cytotoxicity assays, circular dichroism spectroscopy, calcein leakage and differential scanning
calorimetry [223-226]. Several diseases associated with misfolding of IDPs have a connection
with their affinity to bind lipid molecules [227]. Misfolding of α-synuclein, which is a fully
disordered protein, and tau proteins, which includes significant amount of disorder, are
examples where disorder and protein-lipid interactions are connected with pathogenic
conditions like the Parkinson's disease, Alzheimer's disease, multiple-system atrophy, and
dementia with Lewy body [224, 225, 228-231]. As another example, SecA from E. coli illustrates
an interaction between IDRs and a lipid bi-layer [232]. Moreover, some bacteriocins, such as
colicin A, unfold to the disordered molten globule state when they interact with the
cytoplasmic lipids of the host cell to perform membrane insertion [233].
Motivated by the recent growth in the annotations of the lipid-interacting IDRs and the
functional importance of these interactions, we present DisoLipPred, first-of-its-kind predictor
of the disordered lipid binding residues (DLBRs). These residues are intrinsically disordered,
interact with lipids and exclude the transmembrane regions. This means that DisoLipPred
produces predictions that complement the results generated with the current predictors of the
transmembrane regions [234-236]. DisoLipPred utilizes a deep neural network to predict
propensity for lipid binding in disordered regions for each amino acid in the input protein
sequence. The design of this tool relies on several innovations. First, we utilize transfer learning.
We start with a more generic network that predicts IDRs that interact with different types of
partner molecules, which is motivated by the large amount of the underlying training data. We
freeze this partner type-agnostic network and extend it to develop the final model that
specializes the predictions to the lipid partners. Second, we use literature to identify
physiochemical properties that are associated with protein-lipid interactions and use them to
expand the inputs to the deep network. Third, we deploy a new training and prediction strategy
that bypasses ordered/structured residues. More specifically, we train the deep network
models using only the native disordered residues to identify DLBRs. This focuses our model on
identifying DLBRs among other disordered residues, compared to a more traditional scenario
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that differentiates DLBRs from both structured and disordered residues. During the prediction
process we use a modern disorder predictor to identify disordered residues which are
processed by our deep network to predict DLBRs. The predicted ordered residues bypass the
network, since by default they exclude DLBRs. We perform ablation analysis that empirically
demonstrates that these innovations lead to significant improvements in the predictive
performance when compared to a more traditional design that exclude these solutions. Such
traditional design is characteristic to the current predictors of the IDRs that interact with
proteins and nucleic acids [92, 102, 105, 195, 206, 237-240].

6.2 Materials and methods
6.2.1

Dataset description

We collect experimental data to establish training and test datasets. We use the training
dataset to design and train the deep network. More specifically, we further subdivide the
training dataset into learning and validation subsets where we use the learning partition (2/3 of
the training dataset) to train the model which we test on the validation partition (1/3 of the
training dataset). We exclude the test set from the training process and use it solely to perform
comparative assessment against other, indirect approaches to predict DLBRs. These datasets
are composed of three types of proteins: proteins with DLBRs, proteins with other IDRs and
fully structured proteins. This allows us to develop and test models that differentiate DLBRs
from other disordered and structured residues. We collect the proteins with IDRs and DLBRs
from version 8 of DisProt [8]. We exclude disordered regions with an ambiguous function or
structure annotations, which are tagged in DisProt. We also exclude the proteins with IDRs that
do not have annotated function to minimize the likelihood of false negative annotations (some
of these IDRs could bind lipids). Moreover, inspired by recent works [166, 205], we further
process the proteins from DisProt to ensure that we use high-quality annotations of structured
regions. Instead of assuming that regions that lack disorder annotations are by default
structured, we map the un-annotated regions to the sequences of the protein structures from
Protein Data Bank (PDB) [241], for which we mask the disordered residues. We utilize the
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protocol from [166] that relies on the alignment with Basic Local Alignment Search Tool (BLAST)
algorithm [155]. The regions in the DisProt sequences that share >90% similarity and e-value
<0.1 with at least one masked PDB sequences are assumed structured. We collect the fully
structured proteins from PDB [241]. We minimize the likelihood that these proteins include
IDRs by collecting high-resolution (<2Å) monomers that do not have disordered regions (i.e.,
structure is resolved for all amino acids) and which map into full UniProt sequences based on
SIFTS [202]. We cluster the combined collection of these three protein types using the CD-HIT
algorithm with 25% similarity [242]. We place the entire clusters into either training or test
datasets, which ensures that these datasets share <25% sequence similarity. The test dataset is
composed of half of the proteins with DLBRs, 100 proteins with other IDRs and 100 structured
proteins. We place the remaining proteins into the training dataset. We use two versions of the
training dataset to implement the transfer learning. The complete training, which we use to
generate the partner type-agnostic deep network, includes the proteins with DLBRs, proteins
with IDRs that interact with other molecules and structured proteins. We transfer this network
into an expanded network that predicts DLBRs and which we train using a resampled training
dataset, which we dub target training dataset. This dataset focuses on the proteins with DLBRs
by undersampling at random 100 proteins with the other IDRs and 100 structured proteins. We
provide details of these datasets, including their overall sizes and numbers of annotated
residues, in the Table 11.
Table 11: Description of the training and test datasets.

Dataset
Complete training dataset
Target training dataset
Test dataset

Number of residues
disordered lipid
disordered
all
binding
1,921
141,018
2,426,416
1,921
17,823
96,015
1,471
20,623
106,348

Number of proteins
fully structured

all

1,446
100
100

2,892
211
219

We use a secondary test dataset to empirically assess whether DisoLipPred’s predictions of
DLBRs in fact exclude the transmembrane regions. We sourced this TM (transmembrane) test
dataset from a recent study that introduced SCAMPI2 predictor of the transmembrane regions
[234]. We clustered the transmembrane proteins used in that study together with the proteins
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from the complete training dataset using CD-HIT at 25% similarity and selected the
transmembrane proteins from clusters that exclude the training proteins. We combine these
transmembrane proteins with the transmembrane proteins from the test dataset to devise the
TM dataset. This dataset includes 25 proteins, 15,978 amino acids and 4,308 transmembrane
spanning residues, and shares <25% sequence similarity to the training datasets.
6.2.2

DisoLipPred architecture

The prediction workflow of the DisoLipPred consists with four main components as shown in
Figure 24, namely bypass module, sequence profile module, neural networks and rescaling
module. The input protein sequence is first processed by SPOT-Disorder [198], one of the most
accurate disorder predictors according to multiple recent assessments including the CAID
experiment [69, 166, 205]. The SPOT-Disorder’s predictions are fed into the bypass module that
separates the predicted disordered residues, which are subsequently processed by the deep
network to predict DLBRs, from the predicted order residues, which bypass the deep network
prediction. Next, sequences of proteins with the predicted disordered residues are used to
derive sequence profiles. The profiles incorporate sequence-derived structural and functional
information that is relevant to the prediction of DLBRs. They are utilized as the input to a deep
neural network that predicts propensity for disordered lipid binding and which is designed using
transfer learning. Finally, the rescaling module normalizes and merges the outputs from the
deep network with the predictions of the ordered residues from the bypass module, producing
the final predictions.
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Figure 24: Prediction workflow of DisoLipPred.

6.2.2.1 Bypass module
DLBRs are localized in the disordered regions. The main challenge for DisoLipPred is to identify
these lipid-binding residues among the other disordered residues. Consequently, during the
training process we train and validate the deep network on the native disordered residues. We
exclude the ordered residues from training since they can be accurately identified with one of
the currently available accurate disorder predictors. We use the highly-accurate SPOT-Disorder
predictor [198] for that purpose. The bypass module separates disordered from ordered
residues based on the SPOT-Disorder’s predictions, such that the putative ordered residues
bypass the prediction process while the putative disordered residues are selected for prediction
with the deep network. The SPOT-Disorder generated propensities for the putative ordered
residues are rescaled and combined with the deep network generated propensities in the
rescaling module to produce the propensities for DLBRs. We use ablation analysis to
demonstrate that the approach that applies the bypass module provides more accurate results
than the direct prediction of DLBRs from all residues.
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6.2.2.2 Sequence profiles
The sequence profiles provide a rich source of information that is relevant to the prediction of
DLBRs and derived directly from the sequences. We use two profiles to facilitate the transfer
learning. One for the partner-agnostic portion of the deep network that aims to predict
interacting disordered residues (red areas in Figure 24) and the other for the part of the deep
network that predicts DLBRs (green areas in Figure 24).
The partner-agnostic profile relies on a comprehensive collection of predictors of structure,
intrinsic disorder and disorder functions, with particular focus on the prediction of the
interacting disordered regions. We use the predictions of the solvent accessibility from
ASAquick [243], secondary structure from PSIPRED [147], disorder from SPOT-Disorder [198],
protein, DNA and RNA interacting disordered regions from DisoRDPbind [104, 105], proteinbinding disordered regions from ANCHOR 2 [195], and disordered linker regions from DFLpred
[107]. This profile is summarized in Appendix 2.
The second profile, which serves as the input to predict DLBRs, focuses on the sequencederived information that is specific to the lipid-binding. We use two relevant structural
properties, the putative solvent accessibility and secondary structure generated with ASAquick
[243] and PSIPRED [147], respectively, putative disorder from SPOT-Disorder [198], and a
curated set of 46 physiochemical properties of amino acids that are associated with proteinlipid interactions [244]. These properties were selected empirically from a comprehensive
collection of over 530 physiochemical indices from the AAindex database [245] based on their
ability to discriminate between lipid-binding and non-lipid binding proteins [244]. They include
hydrophobicity, hydrophobic moment, charge, isoelectric point, transfer energy, Gibbs energy,
solvation free energy, propensity for helical and sheet conformations, and propensity for side
chain interactions. Complete list of these properties is in Appendix 2
6.2.2.3 Transfer learning of the deep recurrent neural network model
Transfer learning is a training strategy where knowledge learned from a source domain/dataset
is transferred to a related target domain/dataset to improve the learning in the target domain
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[246]. This strategy is deployed when the target dataset has limited amount of data compared
to a more data-rich source dataset, and is particularly useful for training the data-hungry deep
neural networks [247]. Transfer learning was recently applied to predict secondary structures of
RNA [248], caspase and metalloprotease cleavage sites [249], MHC‐I peptide binding [250] and
transcription factor binding [251], but it was never used to develop predictors of interacting
disordered regions. Prediction of DLBRs offers an ideal scenario for the transfer learning. While
we have a relatively limited amount of DLBRs (3,392 residues), the amount of the data
concerning a generic set of interacting IDRs is very substantial (161,641 residues). Thus, we first
build a partner-agnostic deep network using the complete training dataset, which we then
freeze and extent with additional layers to develop the target network that predicts DLBRs
using the target training dataset. We adopt deep recurrent networks given their recent success
with the prediction of disorder [198, 199, 203].
The partner-agnostic network consists of two long term-short memory layers that are
sandwiched between fully connected layers with ReLu activation function in the internal layers
and the sigmoid activation function at the output layer (Figure 25A). We use the RMSprop
optimizer, binary cross entropy as the loss function, dropout rate of 0.5 (to minimize
overfitting), and dynamic adjustment of the learning rate which we set to gradually decrease as
the training progresses. This network uses the partner-agnostic profile as the input. We
optimized the number of layers and the number of neurons per layer using an iterative
approach where we start from a small size and increase it by a small increment until AUC
measured for the prediction of interacting IDRs on the validation set decreases in two
consecutive iterations.
The optimized partner-agnostic network is transferred to develop the target network. We
remove the output layer from the partner-agnostic model and freeze it. We connect the last
layer of this network to several additional layers that narrow down the partner-agnostic
prediction to the partner-specific prediction of DLBRs. This network extends the partneragnostic profile with the additional inputs relevant to the prediction of DLBRs that we discuss in
Section 6.2.2.2. This extension includes multiple bidirectional long short-term memory layers
placed between fully connected layers (Figure 25B). Similar to the training of the partner88 | P a g e

agnostic network, we optimize the size of the additional layers using the increment approach
that maximizes AUC for the prediction of DLBRs on the validation set.
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Figure 25: Architecture of the deep recurrent neural network used by DisoLipPred. Panel A shows the
partner-agnostic network that we train using the dataset of IDRs that interact with different partner types.
Panel B gives the network that extends the partner-agnostic network to perform the partner-specific
prediction of DLBRs.

6.2.2.4 Rescaling module
We combine the disordered lipid-binding propensities generated by our deep recurrent neural
network for the disordered residues predicted with SPOT-Disorder and the SPOT-Disorder’s
propensity scores for the predicted ordered residues. First, we normalize the outputs from the
deep neural network to the unit range. We also rescale the SPOT-Disorder’s propensities for
predicted ordered residues, which bypass the neural network, so they cover the 0 to 0.5 range.
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This aims to minimize risk of missing out DLBRs among the incorrect predictions of order from
SPOT-Disorder. This way, these false negatives can be predicted with moderately high scores.

6.3 Results
6.3.1

Ablation analysis of the prediction model

The three main innovations underlying DisoLipPred include the use of the transfer learning,
lipid-binding features and the bypass module. We perform ablation analysis to quantify the
impact of these innovations on the predictive performance of DisoLipPred. To do that, we
compare the results produced by the DisoLipPred model with the three setups where one of
these features is removed and the setup where all three features are removed (Table 12). For
instance, in the setup 1 we exclude transfer learning by removing the partner-agnostic network
and relying solely of the lipid binding neural network. The bypass module works by training and
testing the deep network on the disordered residues and sidestepping the deep network
predictions for the putative ordered residues. The training process utilizes the native disordered
residues while during tests/predictions we use the predictions from SPOT-Disorder. In setup 3,
we evaluate the impact of using the predicted disordered residues for both training and
testing/predictions. The setup 4 excludes all three innovations where for the bypass feature we
train/test the deep network using both disordered and ordered residues. This bare-bone
predictor is comparable to current deep learners that are used to predict disorder [196, 198,
203] and the protein binding IDRs [252, 253]. We trained each of the five setups separately by
maximizing the AUC on the validation set.

90 | P a g e

Table 12: Experimental setups for the ablation study.
Setup
Use of transfer learning
DisoLipPred
Yes
1
No
2
Yes
3
Yes
4
No

Use of lipid features
Yes
Yes
No
Yes
No

Bypass module during training
Native disorder vs native order
Native disorder vs native order
Native disorder vs native order
Predicted disorder vs predicted order
No

Table 13: Predictive performance of DisoLipPred and its variants from the ablation analysis (Table 1) on
the test dataset. We perform the assessment on the complete test dataset, and also on the subset of
disordered residues from the test dataset. We quantify the binary metrics (sensitivity and F1) at the fixed
specificity = 0.9. We assess the statistical significance of the differences between the results produced by
DisoLipPred and each of the variants using procedure explained in Section 2.2. * indicates that DisoLipPred
provides significantly better result (p-value <0.05).

Setup
DisoLipPred
1
2
3
4

AUC
0.781
0.747*
0.745*
0.726*
0.678*

Complete test dataset
Sensitivity Specificity
0.382
0.900
0.290*
0.900
0.327*
0.900
0.260*
0.900
0.123*
0.900

F1
0.145
0.112*
0.125*
0.101*
0.049*

Disordered residues in the test dataset
AUC
Sensitivity Specificity
F1
0.635
0.286
0.900
0.201
0.572*
0.162*
0.900
0.118*
0.603*
0.146*
0.900
0.175*
0.593*
0.177*
0.900
0.129*
0.396*
0.046*
0.900
0.035*

We compare predictive performance of the five setups on the test dataset in Table 13. We
assess the predictions on the complete datasets as well as on the subset of the disordered
residues. The latter evaluation quantifies the ability of these models to solve a more difficult
problem of identifying DLBRs among other disordered regions i.e., DLBR are more similar to
other disordered residues than to the ordered residues.
DisoLipPred offers accurate predictions with AUC = 0.78 and sensitivity = 0.38. This sensitivity is
relatively high given that we measure it at the low FPR = 0.10 (specificity = 0.90). Compared to
the complete DisoLipPred model, we note a noticeable and statistically significant drop in the
predictive performance for all metrics and ablation variants (p-value < 0.05). Among the setups
where one of the innovations is removed, the largest drop is for the setup 3 where we
manipulate the bypass feature. This suggests that our deep networks can be better trained to
recognize DLBR among native disordered residues than among the predicted disordered
residues. The errors from the disorder predictions and the networks training seem to
91 | P a g e

accumulate in the latter case. The results further substantially decline when all three
innovations are removed (setup 4). This means that the contributions of the novel design
features are complementary.
As expected, tests on the native disordered residues (right side of Table 13) lead to lower
predictive performance across all methods. However, DisoLipPred still provides reasonably
accurate predictions (AUC = 0.64 and sensitivity = 0.29 at FPR = 0.1). The ablation variants
consistently underperform compared to the complete model (p-value < 0.05), with the barebone model performing at the random levels: AUC < 0.55 and sensitivity and F1 near 0. This
demonstrates that the basic deep network is incapable of predicting DLBRs since it can only
solve the trivial problem of differentiating DLBRs from ordered residues (AUC = 0.68 on the
complete dataset vs. 0.40 on the disordered residues). In other words, the three innovations
that we introduce are essential to provide accurate predictions.
6.3.2

Comparative assessment on the test dataset

We compare DisoLipPred to current alternatives that can be indirectly used to predict DLBR.
We consider three categories of the indirect predictors. First, we include methods that predict
transmembrane regions in protein sequences. We select predictors with publicly available
implementations/servers that include one recently released method, SCAMPI 2 [234], and one
older and highly-cited method, Phobius [235]. While DLBRs predicted by DisoLipPred exclude
transmembrane regions, we investigate whether the transmembrane region predictors could
be used to also predict DLBRs. Second, we cover disorder predictors since DLBR are one of the
functional subtypes of the disordered residues. We choose 10 disorder predictors that were
considered in recent comparative surveys [69, 166]: DisEMBL‐465 (trained using X‐ray
structures) and DisEMBL‐HL (trained to predict disorder-like loop conformations) [54]; three
versions of ESpritz [65]: ESpritz‐Xray (trained on X‐ray structures), ESpritz‐NMR (trained on
NMR structures) and ESpritz‐DisProt (trained on the DisProt database data); two flavors of
IUPred [52, 193]: IUPred‐short (trained to predict short IDRs) and IUPred‐long (trained to
predict long IDRs); GlobPlot [54] and SPOT-Disorder [198]. Third, we include representative
predictors of disorder function, such as DisoRDPbind [104, 105] that predicts the disordered
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RNA binding, DNA binding and protein binding residues, ANCHOR 2 [195] that predicts
disordered protein binding residues and DFLpred [107] which predicts disordered linkers.
Finally, we compute a baseline results based on sequence alignment to the training proteins.
We perform this alignment with BLAST [155], where DLBR annotations are transferred from the
aligned positions in the most similar training proteins that secures e-value < 1.0. We setup the
e-value parameter to maximize performance on the test dataset.
Table 14: Predictive performance on the test dataset. We perform the assessment on the complete test
dataset, and also on the subset of the native disordered residues from the test dataset. We quantify the
binary metrics (sensitivity and F1) at the fixed specificity = 0.9. for the predictors that produce the
propensity scores. We use the default sensitivity, F1, and specificity values for the other three methods
that produce only binary predictions: SCAMPI 2, Phobius and BLAST. We assess the statistical significance
of the differences between the results produced by DisoLipPred and every other tool using procedure
explained in Section 2.2. * indicates that DisoLipPred provides significantly better result (p-value <0.05).
Methods are sorted in the ascending order by their AUC within each predictor type group.
Predictor
Type
Name
Transmem- SCAMPI 2
brane regions Phobius
Baseline
BLAST alignment
DFLpred
DisoRDPbind-RNA
Disorder
function
ANCHOR
predictors
DisoRDPbind-Protein
DisoRDPbind-DNA
GlobPlot
ESpritz-NMR
disEMBL-465
disEMBL-HL
IUPred-long
Disorder
predictors
IUPred-short
ESpritz-Xray
VSL2B
SPOT-Disorder
ESpritz-DisProt
DLBR
DisoLipPred
predictor

Complete test dataset
AUC Sensitivity F1 Specificity
N/A
0.019* 0.016*
0.98
N/A
0.016* 0.024*
1.00
N/A
0.000* 0.000*
1.00
0.338* 0.037* 0.015*
0.90
0.450* 0.035* 0.014*
0.90
0.637* 0.229* 0.090*
0.90
0.556* 0.016* 0.006*
0.90
0.636* 0.211* 0.083*
0.90
0.530* 0.225* 0.088*
0.90
0.571* 0.216* 0.085*
0.90
0.610* 0.119* 0.048*
0.90
0.619* 0.143* 0.056*
0.90
0.626* 0.256* 0.100*
0.90
0.632* 0.257* 0.100*
0.90
0.659* 0.114* 0.046*
0.90
0.673* 0.205* 0.081*
0.90
0.692* 0.155* 0.062*
0.90
0.768* 0.355* 0.135*
0.90
0.781

0.382

0.145

0.90

Disordered residues in the test dataset
AUC Sensitivity F1 Specificity
N/A
0.019* 0.035*
0.99
N/A
0.016* 0.031*
1.00
N/A
0.000* 0.000*
1.00
0.554*
0.109* 0.081*
0.90
0.517*
0.028* 0.022*
0.90
0.446*
0.178* 0.129*
0.90
0.276*
0.002* 0.001*
0.90
0.554*
0.062* 0.047*
0.90
0.482*
0.167* 0.123*
0.90
0.412*
0.113* 0.084*
0.90
0.433*
0.048* 0.037*
0.90
0.477*
0.066* 0.050*
0.90
0.420*
0.167* 0.123*
0.90
0.441*
0.142* 0.105*
0.90
0.428*
0.070* 0.053*
0.90
0.433*
0.057* 0.045*
0.90
0.361*
0.043* 0.033*
0.90
0.498*
0.065* 0.049*
0.90
0.635

0.286

0.201

0.90

Table 14 compares DisoLipPred’s predictive performance against the indirect predictors and the
baseline. We derive the binary predictions from the propensity scores using thresholds that we
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adjust to set FPR = 0.1 (specificity = 0.9). This allows us to directly compare the other binary
metrics (sensitivity and F1) between methods. DisoLipPred provides accurate predictions of
DLBRs on the test dataset, with AUC = 0.78 and sensitivity = 0.38 at FPR = 0.10. The latter means
that DisoLipPred offers 3.8-fold increase in the rate of correct to incorrect predictions. Tests of
statistical significance of differences reveal that the DisoLipPred’s predictions are significantly
better than the results of all 17 indirect methods and the baseline (p-value < 0.05). The poor
performance of the baseline alignment stems from the low sequence similarity, < 25%, between
the training and test proteins. The most accurate of the indirect predictors include Espritz-DisProt
(AUC = 0.77, sensitivity = 0.35), SPOT-Disorder (AUC = 0.69, sensitivity = 0.16), and VSL2B (AUC =
0.67, sensitivity = 0.21). The ROC curves the test dataset for the best-performing methods,
including DisoLipPred, SPOT-Disorder, VSL2B, Espritz-DisProt, are available in the Supplementary
Figure S in Appendix 21 They reveal a large margin of improvement for DisoLipPred, particularly
for low values of FPRs, i.e., conservative predictions where rate of false positives is low. We
highlight the results from the two predictors of transmembrane regions that secure near zero
(0.02) sensitivity at 0.1 specificity, which means that they do not predict DLBRs. We conduct a
further comparison with the two transmembrane region predictors in 6.3.4 using a separate
dataset of proteins with transmembrane regions.
The relatively high AUCs of several disorder predictors on the test dataset can be explained by
the fact that they accurately differentiate DLBRs from the ordered residues. However, the
results computed on native disordered residues in the test dataset (the right side of Table 14)
reveal that these methods cannot reliably discriminate DLBRs from the other disordered
residues. More specifically, AUCs of the top disorder predictors, Espritz-DisProt, SPOT-Disorder,
VSL2B, are 0.50, 0.36 and 0.43, respectively. Overall, only DisoLipPred generates accurate
results on the disordered residues while the other predictors are significantly worse (p-value <
0.05) and their performance is near random levels (AUC < 0.55). This is expected since none of
the indirect tools were designed to predict DLBRs.
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6.3.3

DisoLipPred predictions on the Saccharomyces cerevisiae proteome

We apply DisoLipPred to predict DLBRs for the complete Saccharomyces cerevisiae proteome
that we source from UniProt [254]. The Baker’s yeast proteome includes 6,049 protein
sequences and 2,936,363 residues. This is one of the best-annotated proteomes; BUSCO
(Benchmarking Universal Single-Copy Orthologs) scores its completeness at 99.6% [255]. We
calibrate the binary predictions to 0.48% prediction rate (% putative DLBRs in the genome),
which corresponds to the rate of the native DLBRs in the DisProt database. We exclude the
putative DLBRs if they form segments of < 6 consecutive residues since the shortest
experimentally annotated disordered lipid binding regions in DisProt are 6 residues long. We
share these predictions on the DisoLipPred’s website at
http://biomine.cs.vcu.edu/servers/DisoLipPred/. We predict that about 4.9% of the yeast
proteins have putative DLBRs (Figure 26A). Majority of these proteins have less than 5% of
residues predicted as DLBRs, however, about 0.7% of the yeast proteins have a substantial
amount of over 5% DLBRs (Figure 26B).

% of yeast proteins with a
given DLBR content

Disordered Lipid Binding Proteins
non-Lipid Binding Proteins

4.91%

95.09%

A

B

2.5
2.0
1.5
1.0
0.5
0.0

(0,0.02]
0.02-0.05
0.05-0.1
>0.1
Predicted DLBR content (% residues with DBLRs)

Figure 26: Summary of the DisoLipPred’s predictions on the Saccharomyces cerevisiae proteome. Panel A
shows the fraction of the yeast proteins predicted to have DLBRs. Panel B is the histogram of the putative
content of DLBRs for the 4.9% of the yeast proteins with DLBRs.

We validate these predictions using the gene ontology (GO) annotations from UniProt. These
annotations are independent of the ground truth data used in the test dataset. First, we select
a subset of the yeast proteins that include the “lipid” keyword in their molecular function GO
term and the “membrane” keyword within their cellular component GO term. The resulting set
of 309 proteins is likely to be enriched in the proteins that have DLBRs; we call it GO lipid
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associated protein set. Second, we compute the rate of proteins predicted to have DLBRs in the
GO lipid associated protein set using DisoLipPred and compare it to the rate of these
predictions generated with the second-best ESpritz-DisProt method (Table 14). We calibrate the
ESpritz-DisProt’s predictions the same way as the predictions from DisoLipPred. Third, we
calculate the expected rate of proteins with the putative DLBRs in the yeast proteome. We
compute the rate for a randomly selected set of 309 yeast proteins and repeat this experiment
100 times to establish distribution of the expected rates. The results are summarized in Figure
27.

A

B

Figure 27: Analysis of the DisoLipPred predictions (Panel A) and the Espritz-DisProt predictions (panel B)
for the yeast proteins. The black arrows identify the rate of the putative proteins with DLBRs in the GO
lipid associated protein set (i.e., set of 309 yeast proteins that share “lipid” keyword in the molecular
function GO term and the “membrane” keyword in the cellular component GO term). Red lines show the
distributions of the expected rates of the putative proteins with DLBRs, which we establish based on
measuring the rate for 100 randomly selected sets of 309 yeast proteins.

The mean of the distribution for DisoLipPred’s predictions is 4.9% (Figure 27A) and corresponds
to the overall rate of proteins with DLBRs in yeast (Figure 26A). DisoLipPred predicts 10.3% of
proteins in the GO lipid associated protein set as having DLBRs. This rate doubles the expected
rate of 4.9% and the difference is statistically significant based on the distribution of the
expected values in Figure 27A (p-value < 0.01). On the other hand, the calibrated predictions
from ESpritz‐DisProt identify only 0.97% of the GO lipid associated protein set as having DLBRs.
This rate is below the expected rate of the ESpritz‐DisProt’s predictions (red line in Figure 27B),
for which median is 1.5%. This suggests that the GO lipid associated proteins are overall
depleted in disorder. In spite of the disorder depletion, the rate of the DisoLipPred’s predictions
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of DLBRs is 10.3/0.97 = 10.6 times higher that the rate of the ESpritz‐DisProt’s predictions,
providing further support for our claim that DisoLipPred’s predictions are accurate.
6.3.4

DisoLipPred prediction assessment on transmembrane proteins

Given that DLBR are defined as disordered lipid-binding regions that exclude transmembrane
segments, we empirically evaluate whether the DisoLipPred’s predictions in fact exclude the
transmembrane residues. We test DisoLipPred and the two representative predictors of the
transmembrane regions, SCAMPI 2 [234] and Phobius [235], on the TM dataset (Table 15). We
introduce the TM dataset in the section 6.2.1. Here, we use the predictions from these three
tools to identify native transmembrane regions, i.e., transmembrane residues are set as the
positives while the other residues, including a small amount of DLBRs, are set as negatives.
Since SCAMPI 2 and Phobius produce only binary predictions and thus their prediction rate
cannot be calibrated, we adjust the rate of the DisoLipPred’s predictions to match the
specificity of each of the two transmembrane predictors. Table 15 shows that as expected
SCAMPI 2 and Phobius provide accurate predictions of the transmembrane regions based on
their high sensitivity scores, i.e., 0.79 sensitivity at the low 0.09 FPR and 0.57 sensitivity at the
low 0.06 FPR, respectively. Their predictive positive rate (PPR) defined as the rate of true
positives among the predicted positives is also relatively high and equals 0.28 and 0.20,
respectively. In stark contrast, DisoLipPred’s sensitivity values calibrated to the rate of
predictions from SCAMPI 2 and Phobius are 0.04 and 0.03, demonstrating that it predicts very
few transmembrane resides as DLBRs. These values are substantially smaller than the
corresponding sensitivity values on the test dataset (Supplementary Figure S1 in Appendix 2.
DisoLipPred’s PPR is higher than its corresponding sensitivity because several proteins in this
dataset include DLBRs, which by definition do not overlap with transmembrane regions.
Altogether, these results show that DisoLipPred accurately differentiates between the
transmembrane regions and DLBRs. Moreover, given the correspondingly low sensitivity of
SCAMPI 2 and Phobius for the prediction of DLBRs (Table 14), we conclude that DisoLipPred
predicts lipid interacting residues that complement the results produced by the predictors of
the transmembrane regions.
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Table 15: Predictive performance on the TM dataset. The performance is measured assuming that the
native transmembrane regions constitute positive annotations. Both transmembrane predictors (SCAMPI
2 and Phobius) produce only binary predictions and thus their prediction rate cannot be calibrated.
Instead, we calibrate the rate of the DisoLipPred’s predictions to match the specificity of SCAMPI 2 and
Phobius.
Predictor
SCAMPI 2
DisoLipPred at SCAMPI 2 specificity
Phobius
DisoLipPred at Phobius specificity

6.3.5

Sensitivity
0.795
0.041
0.574
0.035

Specificity
0.91
0.91
0.94
0.94

PPR
0.279
0.076
0.197
0.050

F1
0.780
0.063
0.663
0.059

Case study

We illustrate the DisoLipPred’s predictions for one of the test proteins, the Sec-independent
protein translocase protein TatA (UniProt accession number: P69428). Our objective here is to
visualize and explain the predictions, rather than to evaluate their performance. TatA is a
membrane associated protein, which is a subunit of the larger twin-arginine translocation (Tat)
system [226]. The Tat system acts as a facilitator to transport large folded proteins through
cellular membranes by creating a protein conducting channel [256, 257]. TatA contains a long
IDR (positions 21 to 89) which was characterized with NMR [258]. Furthermore, proton based
NMR revealed that part of this IDR (positions 21 to 44) binds to lipids [226]. Figure 28 shows
DisoLipPred’s predictions for TatA along with the abovementioned native annotations of the
disordered and disorder lipid binding regions. DisoLipPred generates relatively high
propensities at the N terminus half of the protein, resulting in the prediction of a long segment
of DLBRs that overlaps with the experimentally determined lipid-binding region. Interestingly,
we predict that the residues at the N terminus are also lipid binding. DisProt does not offer a
conclusive evidence whether this segment is disordered or structured. Our alignment-based
mapping into PDB (see Section 6.2.1) did not identify a known structure for this segment.
Further investigation of literature reveals support for our prediction, where this segment is
shown to likely interact with lipids of the cell membrane from the cytoplasmic side [259].
Altogether, this prediction agrees with the experimental annotations and provides support for
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the hypothesis that the disordered lipid binding region is larger than DisProt suggests, covering
the N-terminus half of the TatA sequence.

Figure 28: DisoLipPred predictions for TatA protein (Uniprot: P69428; DisProt: DP00834). The blue line in
the top panel shows the residue level propensity scores generated by DisoLipPred. The horizontal blue
bars at the bottom are the corresponding experimental annotation of lipid binding regions and the binary
prediction from DisoLipPred. The horizontal red bar shows the experimental annotation of the intrinsic
disorder, where grey color identifies regions that lack disorder/order annotations.

6.3.6

Webserver

DisoLipPred is freely available as a webserver at http://biomine.cs.vcu.edu/servers/DisoLipPred/.
DisoLipPred webserver takes up to two amino acid sequences in the FASTA format as the input.
The entire prediction process is automated, done on the server side and takes about 2-4 minutes
for an average size protein. Users can optionally provide an email address where we send a
notification email with the of the unique URL of results once the prediction is completed. The
webserver provides the output propensities and binary predictions for each amino acid in the
input protein sequence(s). The threshold that we use to generate the binary predictions
corresponds to the 10% FPR on the training dataset. The outputs are available in two
complementary formats: as a parsable text file and an interactive figure. The figure provides a
graphical summary of the predictions with the zoom in/ out functions, ability to hide userselected panels and take a screenshot, and mouse hover that shows additional information.
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6.3.7

Summary

IDRs interact with many partner molecules including proteins, RNA, DNA and lipids. Sequencebased prediction of these IDRs is currently possible for the interactions with proteins and nucleic
acids [171-173, 180]. Motivated by the growing amount of experimental data and the need to
expand coverage of the current predictors, we have designed, implemented, validated and
deployed a novel computational approach, DisoLipPred. This first-of-its-kind predictor accurately
identifies DLBRs within intrinsically disordered protein regions. Our solution implements three
innovative features that include the application of transfer learning, bypass module and selected
physiochemical properties associated with protein-lipid interactions.
We deliver a multifaceted validation of the predictions produced by DisoLipPred. The ablation
tests show that the quality of the DisoLipPred predictions is fueled primarily by the three
innovations. Analysis on the test dataset reveals that DisoLipPred generates accurate predictions
and that current tools that could be indirectly used to identify DLBR cannot differentiate the lipidinteracting residues from the other disordered residues. Validation on the complete yeast
proteome provides further support for the claim that DisoLipPred produces accurate results.
Moreover, we demonstrate empirically that the DisoLipPred’s predictions complement the
results produced by the predictors of the transmembrane regions. Altogether, our analysis
suggests that DisoLipPred provides high-quality predictions of DLBRs that complement the
currently available tools. DisoLipPred is available via a convenient webserver at
http://biomine.cs.vcu.edu/servers/DisoLipPred/.

100 | P a g e

Chapter 7. Summary
This thesis focuses on multiple aspects related to the computational prediction of the intrinsic
disorder and disorder functions. We started with an innovative study that evaluates the
predictive performance of disorder predictors at their protein level. This analysis suggests that
the predictive performance of disorder predictors should not be adjudicated solely based at the
dataset level results. This is because the protein-level results are very different from what the
dataset-level assessments suggest. Our analysis that spans a dozen disorder predictors shows
that the protein level predictive performance has a consistent wide distribution with long tails at
the lower range of predictive performance. This shape of distribution reveals that majority of
protein level predictions should have higher than expected quality (higher than the protein-level
results). However, a large number of proteins at the long tails are predicted very poorly. We also
reveal that the predictive performance of disorder predictors is correlated with the amount of
the native disorder content. To be more specific, the performance of disorder predictors
substantially drops for proteins with higher disorder content. Finally, our study suggests that
disorder predictors provide complementary results. This means that none of them is capable of
providing the “silver-bullet” solution.
The objective 2 investigates the possibility of building a recommender system that would suggest
a suitable disorder predictor for a given protein sequence. This objective is motivated by the
diversity of the protein-level predictive performance values within and across current disorder
predictors, which we identified under objective 1. We present a novel framework that predicts
expected predictive performance of a given disorder predictor for the input protein, and uses
these results collected over a set of disorder predictors to select the most accurate method. We
use the physiochemical and putative structural properties of the input protein sequence to
generate accurate prediction of the predictive performance. Extensive empirical tests
demonstrate that our recommender system, DISOselect, significantly outperforms all current
solutions, which include 12 representative disorder predictors and selected classical metamodels. We provide DISOselect to the research community as a webserver.
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The third objective investigates the predictive performance of a selected set of 10 representative
disorder predictors for two key functional subclasses of IDPs: disordered protein binding proteins
and disordered nucleic acid binding proteins. We introduce three novel aspects in this analysis to
address drawbacks of the past disorder predictor evaluations. We are the first to create a
benchmark dataset with test proteins for which similarity was reduced with respect to the
training datasets of predictors that we evaluate. Second, we use experimentally validated
annotations of the ordered regions. Finally, we compare the predictive performance for a generic
set of disordered proteins with the performance on the disordered protein binding and the
disordered nucleic acid binding proteins. Our analysis reveals that similarity reduction of the
benchmark dataset with respect to the training datasets results in a substantial reduction of the
predictive performance when compared to the performance reported in previous studies where
benchmark datasets do not limit the similarity. This suggests that the prior studies overestimate
the predictive equality of disorder predictors. We also show that use of the experimentally
validated ordered regions has a positive impact on the measured predictive performance. This
stems from the fact that the ground truth concerning the order annotations has higher quality.
Most importantly, we reveal that disorder predictions for the disordered nucleic acid binding
proteins are accurate and share similar quality with the predictions for generic disordered
proteins. However, disorder predictions for the disordered protein binding proteins suffer lower
predictive performance, suggesting that future disorder predictors should focus on optimizing
predictions for these proteins.
In the fourth and final objective we design and develop DisoLipPred, the first method that
predicts disordered lipid-binding residues (DLBRs) in protein sequences. We introduce three
innovations in the development of DisoLipPred. First, we use transfer learning based deep
recurrent neural network. The transfer learning utilizes related large data concerning ligandagnostic interactions in IDRs to facilitate/kickstart the design of the network module responsible
for the predictions of DLBRs. We also utilize the bypass training strategy to train the model using
native disordered regions and use it to make predictions for the predicted disordered residues.
These predictions are combined with the predictions of the ordered residues. The main purpose
behind the bypassing strategy is to improve the neural network’s ability to identify DLBRs among
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native disordered residues. The third innovation identifies physiochemical properties of proteins
which are associated with lipid binding using literature and uses them to enhance inputs to the
deep neural network. Ablation analysis shows that there three innovations are the main drivers
behind the ability of DisoLipPred to accurately predict DLBRs. We also evaluate the DisoLipPred’s
predictive performance against multiple alternative/indirect prediction methods on an
independent test dataset (i.e., test proteins are dissimilar to the proteins in the training dataset).
This test shows that DisoLipPred is the only tool that provides accurate predictions of DLBRs.
Moreover, we show that DisoLipPred does not cross-predict transmembrane protein regions as
DLBRs using a separate test dataset of the transmembrane proteins. Comparison of DisoLipPred
against two representative predictors of the transmembrane regions shows that these tools
provide complementary results. We apply DisoLipPred to make predictions on the complete
yeast proteome. This prediction facilitates additional evaluation using the gene ontology
annotations, which further confirms that DisoLipPred provides accurate results. Lastly, we
provide DisoLipPred to the research community as a publicly available webserver.
The work covered in the first three objectives was recently published in reputed peer-reviewed
journals [125, 140, 166].

7.1 Major contributions
My major contributions related to specific objectives are as follows.
Objective 1: Elucidation and comparative analysis of protein-level predictive performance for
current disorder predictors.
•

Evaluated the predictive performance of disorder predictors at individual protein level
and contrasted it to their dataset level performance.

•

Investigated the complementarity of predictive performance across selected set of 13
computational disorder predictors both at the protein and dataset levels.

•

Investigated the impact of disorder content of individual proteins to their predictive
from selected set of 13 computational disorder predictors.
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Objective 2: Development of a novel protein-level predictor recommendation system to
improve predictive performance of disorder predictions.
•

Investigated the usefulness of physiochemical properties to predict expected predictive
performance for individual proteins from selected set of computational disorder
predictors. To the best of my knowledge, this is the first published study on this topic.

•

Designed, developed and tested the machine learning (regression) based approach to
predict expected predictive performance of a given protein for an individual disorder
predictor.

•

Designed, implemented and tested the DISOselect system that recommends the most
accurate disorder predictor for a given input protein. To the best of my knowledge this
is first such recommendation system for the computational disorder predictors.

•

Developed and deployed the webserver that implements the DISOselect method.

Objective 3: Assessment and comparative analysis of the predictive performance of disorder
predictions for specific functional types of disordered proteins.
•

Collected and annotated the benchmark dataset.

•

Created the similarity reduced benchmark dataset by clustering initial dataset with
training datasets of evaluating predictors.

•

Validated the experimental annotations for ordered regions by mapping them to a
masked database of PDB sequences.

•

Collected the disorder predictions from 10 different methods for the benchmark
dataset.

•

Evaluated the impact of similarity reduction of benchmark dataset to the predictive
performance of the 10 selected methods.

•

Evaluated the impact of the experimental validation of ordered regions on the
predictive performance of the 10 selected methods.

•

Evaluated the predictive performance of 10 selected methods for the functional
subclasses of disordered proteins.
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Objective 4: Accurate prediction of the disordered lipid-binding residues from protein
sequences.
•

Collected and functionally annotated the training and test datasets.

•

Identified and investigated the usefulness of different physicochemical features to
predict disordered lipid-binding residues.

•

Designed and implemented DisoLipPred including the novel approach of using transfer
learning and bypass strategy to predict the disordered lipid-binding residues from
protein sequences.

•

Collected the results and empirically assessed predictive performance of DisoLipPred
against several approaches that can be used to indirectly predict the disordered lipidbinding residues.

•

Evaluated the predictive performance of DisoLipPred on the benchmark test dataset, on
the TM test dataset and on the complete yeast proteome.

•

Developed and deployed a freely available webserver that implements the DisoLipPred
method.
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Glossary
This section briefly describes the key terminology used in this document (in alphabetical order).
Disorder Function: A biological or biochemical function that is assigned to an intrinsically
disordered region or intrinsically disordered protein.
Disorder Predictor: A computational method which predict disorder for individual amino acids
in the protein sequence.
Disordered Protein: A Protein that includes one or more intrinsically disordered regions.
Disordered Region: A unique amino acid sequence that have no single, well-defined equilibrium
structure and exist as highly dynamic, heterogeneous ensembles of conformers resulting from
their relatively flat free energy surface.
Individual Protein Level: A complete protein sequence. Individual proteins usually have unique
identifiers that rely on a well-defined naming convention.
Protein Dataset: A collection of multiple proteins, typically used to perform assessment of
disorder predictors.
Protein Region Level: A sequence of multiple consecutive residues in a single protein.
Protein Residue Level: The smallest building unit of proteins. This unit is also referred to as an
amino acid.
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Appendix 1 – Complete set of 130 features used to implement the disorder predictor recommendation
system (the DISOselect method)
Category

Amino Acid
composition
(20 features)

Predicted
Solvent
Accessibility
(3 features)
Sequence
Complexity
(2 features)
Predicted
Secondary
Structure
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Feature name

Description

Alanine Content
Leucine Content
Arginine Content
Asparagine Content
Aspartic Content
Cysteine Content
Glutamic Content
Glutamine Content
Glycine Content
Histidine Content
Isoleucine Content
Lysine Content
Methionine Content
Phenylalanine Content
Proline Content
Serine Content
Threonine Content
Tryptophan Content
Tyrosine Content
Valine Content

Fraction of Alanine in the input protein chain
Fraction of Leucine in the input protein chain
Fraction of Arginine in the input protein chain
Fraction of Asparagine in the input protein chain
Fraction of Aspartic acid in the input protein chain
Fraction of Cysteine in the input protein chain
Fraction of Glutamic acid in the input protein chain
Fraction of Glutamine in the input protein chain
Fraction of Glycine in the input protein chain
Fraction of Histidine in the input protein chain
Fraction of Isoleucine in the input protein chain
Fraction of Lysine in the input protein chain
Fraction of Methionine in the input protein chain
Fraction of Phenylalanine in the input protein chain
Fraction of Proline in the input protein chain
Fraction of Serine in the input protein chain
Fraction of Threonine in the input protein chain
Fraction of Tryptophan in the input protein chain
Fraction of Tyrosine in the input protein chain
Fraction of Valine in the input protein chain

Source
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence
Input sequence

Total accessible surface area

Sum of solvent accessibility of all residues

Predicted with ASAquick [260]

Average accessible surface area
Total number of exposed
residues
Fraction of complex regions

Average of solvent accessibility of all residues

Predicted with ASAquick [260]

Sum of binary exposed residues

Predicted with ASAquick [260]

Number of complex regions divided by chain length

Computed by SEG [137]

Fraction of complex residues

Number of complex residues divided by chain length

Computed by SEG [137]

Count of coils

Count of putative coil residues in protein

Predicted with PSIPRED [147]

Count of helices

Count of putative helix residues in protein

Predicted with PSIPRED [147]

(8 features)

Count of strands

Count of putative strand residues in protein

Predicted with PSIPRED [147]

Count of coils and strands

Count of putative coil and strand residues in protein

Predicted with PSIPRED [147]

Content of coils

Fraction of putative coil residues in the input protein chain

Predicted with PSIPRED [147]

Content of helices

Fraction of putative helix residues in the input protein chain

Predicted with PSIPRED [147]

Content of strands

Fraction of putative strands residues in the input protein chain

Predicted with PSIPRED [147]

Content of coils and strands

Fraction of putative coils and strand residues in the input protein chain

Predicted with PSIPRED [147]

Summed hydropathy

Sum of hydropathy values of all residues

Extracted from AAindex [245]: KYTJ820101

Summed net charge

Sum of net charge values of all residues

Extracted from AAindex [245]: KLEP840101

Summed hydrophilicity

Sum of hydrophilicity values of all residues of all residues

Extracted from AAindex [245]: HOPT810101

Average hydrophilicity

Sum of hydrophilicity values divided by chain length

Extracted from AAindex [245]: HOPT810101

Average absolute entropy

Sum of absolute entropy values divided by chain length

Extracted from AAindex [245]: HUTJ700102

Average unfolding gibbs energy

Sum of unfolding Gibbs energy values divided by chain length

Extracted from AAindex [245]: YUTK870101

Average beta coils

Sum of beta-structure-coil equilibrium constants divided by chain length

Extracted from AAindex [245]: OOBM850101

Average reverse turns

Sum of propensities to form reverse turn divided by chain length

Extracted from AAindex [4]: OOBM850102

Summed transfer energy

Sum of transfer energy parameters of all residues

Extracted from AAindex [4]: OOBM850103

Average Isoelectricity

Sum of isoelectric points divided by chain length

Extracted from AAindex [4]: ZIMJ680104

Sequence complexity

Sum of composite amino acid of all residues

Raw sequence

Summed hydrophobicity

Sum of hydrophobicity values of all residues

Extracted from AAindex [4]: PRAM900101

Sum of hydrophobicity values divided by chain length

Extracted from AAindex [4]: PRAM900101

Sum of hydropathy values divided by chain length

Extracted from AAindex [4]: KYTJ820101

Physiochemical Average hydrophobicity
properties of
Average hydropathy
amino acids
(97 features)
Summed solvation free energy
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Sum of solvation free energy values of all residues

Extracted from AAindex [4]: EISD860101

Average solvation free energy

Sum of solvation free energy values divided by chain length

Extracted from AAindex [4]: EISD860101

Summed polarity

Sum of polarity values of all residues

Extracted from AAindex [4]: GRAR740102

Average polarity

Sum of polarity values divided by chain length

Extracted from AAindex [4]: GRAR740102

Summed volume

Sum of volume values of all residues

Extracted from AAindex [4]: GRAR740103

Average volume

Sum of volume values divided by chain length

Extracted from AAindex [4]: GRAR740103

Summed absolute entropy

Sum of absolute entropy values of all residues

Extracted from AAindex [4]: HUTJ700102

Summed unfolding gibbs

Sum of unfolding Gibbs energy in water of all residues

Extracted from AAindex [4]: YUTK870101

Summed activation gibbs

Sum of activation Gibbs energy values of all residues

Extracted from AAindex [4]: KLEP840101

Average activation gibbs

Sum of activation Gibbs energy values divided by chain length

Extracted from AAindex [4]: KLEP840101

Summed beta coils

Sum of beta-structure-coil equilibrium constants of all residues

Extracted from AAindex [4]: OOBM850101

Summed reverse turn

Sum of propensity to form reverse turn values of all residues

Extracted from AAindex [4]: OOBM850102

Average transfer energy

Sum of transfer energy parameters divided by chain length

Extracted from AAindex [4]: OOBM850103

Summed isoelectric points

Sum of isoelectric points values of all residues

Extracted from AAindex [4]: ZIMJ680104

Summed charge transfer

Sum of parameter of charge transfer capability of all residues

Extracted from AAindex [4]: CHAM830107

Summed charge donor

Sum of parameter of charge donor capability of all residues

Extracted from AAindex [4]: CHAM830108

Summed positive charge

Sum of parameter of positive charge capability of all residues

Extracted from AAindex [4]: CHAM830108

Summed negative charge

Sum of parameter of negative charge capability of all residues

Extracted from AAindex [4]: CHAM830108

Summed hydrophobicity index

Sum of hydrophobicity Index values of all residues

Extracted from AAindex [4]: ARGP820101

Average hydrophobicity index

Sum of hydrophobicity Index values divided by chain length

Extracted from AAindex [4]: ARGP820101

Summed alpha hydrophobicity

Sum of normalized hydrophobicity scales for alpha-proteins of all residues
Extracted from AAindex [4]: CIDH920101
Sum of normalized hydrophobicity scales for alpha-proteins divided by chain
Extracted from AAindex [4]: CIDH920101
length

Average alpha hydrophobicity
Summed normalized average
hydrophobicity
Average normalized average
hydrophobicity
Summed consensus normalized
hydrophobicity
Average consensus normalized
hydrophobicity
Summed average surrounding
hydrophobicity
Average surrounding
hydrophobicity
Summed hydrophobicityPH3
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Sum of normalized average hydrophobicity scales of all residues

Extracted from AAindex [4]: CIDH920105

Sum of Normalized average hydrophobicity scales divided by chain length

Extracted from AAindex [4]: CIDH920105

Sum of consensus normalized hydrophobicity scales of all residues

Extracted from AAindex [4]: EISD840101

Sum of Consensus normalized hydrophobicity scales divided by chain length

Extracted from AAindex [4]: EISD840101

Sum of average surrounding hydrophobicity values of all residues

Extracted from AAindex [4]: MANP780101

Sum of average surrounding hydrophobicity values divided by chain length

Extracted from AAindex [4]: MANP780101

Sum of hydrophobicity index values at 3.0 pH of all residues

Extracted from AAindex [4]: COWR900101

Average hydrophobicityPH3

Sum of hydrophobicity index values at 3.0 pH divided by chain length

Extracted from AAindex [4]: COWR900101

Summed native hydrophobicity

Sum of native hydrophobicity index values of all residues

Extracted from AAindex [4]: CASG920101

Average native hydrophobicity

Sum of native Hydrophobicity index values divided by chain length

Extracted from AAindex [4]: CASG920101

Disorder complexity

Fraction of disorder promoting amino acids in the input protein chain

Input sequence

Order complexity

Fraction of order promoting amino acids in the input protein chain

Input sequence

Charge to hydropathy ratio
Disorder complexity to order
complexity ratio
Summed mass

Total charge of a protein as ratio of total hydropathy of all residues
Calculated AA index
Ratio between disorder promoting amino acids fraction and order promoting
Input sequence
amino acids fraction in the input protein chain
Sum of masses of all residues
Input sequence

Average mass

Sum of masses divided by chain length

Input sequence

Summed density

Total mass of a protein as a ratio of total volume of all residues

Calculated AA index

Average density

Total density of protein divided by chain length

Calculated AA index

Length of each protein

Number of amino acids in the input protein chain

Input sequence

Summed CH chemical shifts

Sum of alphaCH chemical shift values of all residues

Extracted from AAindex [4]: ANDN920101

Average CH chemical shifts

Sum of alphaCH chemical shift values divided by chain length

Extracted from AAindex [4]: ANDN920101

Summed NH chemical shifts

Sum of alphaNH chemical shift values of all residues

Extracted from AAindex [4]: BUNA790101

Average NH chemical shifts

Sum of alphaNH chemical shift values divided by chain length

Extracted from AAindex [4]: BUNA790101

Summed spin coupling

Sum of spin coupling constants of all residues

Extracted from AAindex [4]: BUNA790103

Average spin coupling

Sum of spin coupling constants divided by chain length

Extracted from AAindex [4]: BUNA790103

Summed membrane preference

Sum of membrane preference indexes of all residues

Extracted from AAindex [4]: DESM900101

Average membrane preference

Sum of membrane preference indexes divided by chain length

Extracted from AAindex [4]: DESM900101

Summed hydrophobic moment

Sum of atom-based hydrophobic moment values of all residues

Extracted from AAindex [4]: EISD860102

Average hydrophobic moment
Summed hydrophobic moment
direction
Average hydrophobic moment
direction
Summed mesophilic B protein
values
Average mesophilic B protein
values
Summed thermophilic B protein
values
Average thermophilic B protein
values
Summed buried fractions

Sum of atom-based hydrophobic moment values divided by chain length

Extracted from AAindex [4]: EISD860102

Sum of direction of hydrophobic moment values of all residues

Extracted from AAindex [4]: EISD860103

Sum of direction of hydrophobic moment values divided by chain length

Extracted from AAindex [4]: EISD860103

Sum of B-values of mesophilic protein distributions of all residues

Extracted from AAindex [4]: PARS000101

Sum of B-values of mesophilic protein distributions divided by chain length

Extracted from AAindex [4]: PARS000101

Sum of B-values of thermophilic protein distributions of all residues

Extracted from AAindex [4]: KUMS000101

Average buried fractions

Sum of ratio of buried and accessible molar fractions divided by chain length Extracted from AAindex [4]: JANJ790101

Summed normalized flexibility

Sum of normalized flexibility parameters of all residues

Extracted from AAindex [4]: VINM940103

Average normalized flexibility
Total average normalized
flexibility
Average normalized flexibility

Sum of normalized flexibility parameters divided by chain length

Extracted from AAindex [4]: VINM940103

Sum of averaged normalized flexibility parameters of all residues

Extracted from AAindex [4]: VINM940101

Sum of averaged normalized flexibility parameters divided by chain length

Extracted from AAindex [4]: VINM940101

Summed beta sheet frequency

Sum of normalized frequency of beta-sheet values of all residues

Extracted from AAindex [4]: PALJ810104

Average beta sheet frequency

Sum of normalized frequency of beta-sheet values divided by chain length

Extracted from AAindex [4]: PALJ810104

Summed 14A contact values

Sum of 14A contact numbers of all residues

Extracted from AAindex [4]: NISK860101

Average 14A contact values

Sum of 14A contact numbers divided by chain length

Extracted from AAindex [4]: NISK860101

Summed beta position 1 affinity

Sum of weights for beta-sheet at the window position of 1 of all residues.
Sum of weights for beta-sheet at the window position of 1 divided by chain
length
Sum of free energies of transfer from bilayer interface to water values of all
residues
Sum of free energies of transfer from bilayer interface to water values divided
by chain length

Extracted from AAindex [4]: QIAN880121

Sum of normalized frequency of beta-structure values of all residues

Extracted from AAindex [4]: NAGK730102

Average beta position 1 affinity
Summed bilayer energy
Average bilayer energy
Summed normalized frequency
of beta structures
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Sum of B-values of thermophilic protein distributions divided by chain length Extracted from AAindex [4]: KUMS000101
Sum of ratio of buried and accessible molar fractions of all residues

Extracted from AAindex [4]: JANJ790101

Extracted from AAindex [4]: QIAN880121
Extracted from AAindex [4]: WIMW960101
Extracted from AAindex [4]: WIMW960101

Average normalized frequency of
Sum of normalized frequency of beta-structure values divided by chain length Extracted from AAindex [4]: NAGK730102
beta structures
Summed optimized side chains Sum of side chain interaction parameter of all residues
Extracted from AAindex [4]: OOBM850105
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Average optimized side chains

Sum of side chain interaction parameter divided by chain length

Extracted from AAindex [4]: OOBM850105

Summed occupancy of water

Sum of fraction of sites occupied by water of all residues

Extracted from AAindex [4]: KRIW790102

Average occupancy of water

Sum of sraction of site occupied by water divided by chain length

Extracted from AAindex [4]: KRIW790102

Summed normalized beta sheets Sum of fraction of site normalized frequency of beta-sheets of all residues
Average normalized beta sheets Sum of fraction of site normalized frequency of beta-sheets divided by chain
length
Summed refractivity
Sum of refractivity of all residues

Extracted from AAindex [4]: CHOP780202

Average refractivity

Sum of refractivity divided by chain length

Extracted from AAindex [4]: MCMT640101

Summed bulkiness

Sum of bulkiness of all residues

Extracted from AAindex [4]: ZIMJ680102

Average bulkiness

Sum of bulkiness divided by chain length

Extracted from AAindex [4]: ZIMJ680102

Extracted from AAindex [4]: CHOP780202
Extracted from AAindex [4]: MCMT640101

Appendix 2 –DisoLipPred supplementary data

Appendix 2 Table 1: Partner-agnostic sequence profile
Description

Source

Predicted disorder propensity

Predicted with SPOT-Disorder [198]

Predicted solvent accessibility

Predicted with ASAquick [243]

Predicted coil propensity

Predicted with PSIPRED [147]

Predicted helix propensity

Predicted with PSIPRED [147]

Predicted strand propensity

Predicted with PSIPRED [147]

Predicted disordered protein binding propensity

Predicted with DisoRDPbind [116]

Predicted disordered DNA binding propensity

Predicted with DisoRDPbind [116]

Predicted disordered RNA binding propensity

Predicted with DisoRDPbind [116]

Predicted flexible linker propensity

Predicted with DFLpred [107]

Predicted disordered protein binding propensity

Predicted with ANCHOR [195]

Appendix 2 Table 2: Extended profile for the prediction of DLBRs.
Description

Source

Predicted disorder propensity

Predicted with SPOT-Disorder [198]

Predicted solvent accessibility

Predicted with ASAquick [243]

Predicted coil propensity

Predicted with PSIPRED [147]

Predicted helix propensity

Predicted with PSIPRED [147]

Predicted strand propensity

Predicted with PSIPRED [147]

Hydropathy

Extracted from AAindex [148]: KYTJ820101

Net charge

Extracted from AAindex [148]: KLEP840101

Polarity

Extracted from AAindex [148]: GRAR740102

Unfolding Gibbs energy values in water

Extracted from AAindex [148]: YUTK870101

Transfer energy

Extracted from AAindex [148]: OOBM850103

Solvation free energy

Extracted from AAindex [148]: EISD860101

Absolute entropy

Extracted from AAindex [148]: HUTJ700102

Isoelectric point

Extracted from AAindex [148]: ZIMJ680104

Charge transfer

Extracted from AAindex [148]: CHAM830107
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Charge donor

Extracted from AAindex [148]: CHAM830108

Positive charge

Extracted from AAindex [148]: FAUJ880111

Negative charge

Extracted from AAindex [148]: FAUJ880112

Argos hydrophobicity

Extracted from AAindex [148]: ARGP820101

Kyte-Doolittle hydrophobicity

Extracted from AAindex [148]: JURD980101

Manavalan-Ponnuswamy hydrophobicity

Extracted from AAindex [148]: MANP780101

Cowan-Whittaker hydrophobicity

Extracted from AAindex [148]: COWR900101

Casari-Sippl hydrophobicity

Extracted from AAindex [148]: CASG920101

Alpha-CH chemical shifts

Extracted from AAindex [148]: ANDN920101

Spin-spin coupling constants

Extracted from AAindex [148]: GRAR740103

Membrane preference

Extracted from AAindex [148]: DESM900101

Atom-based hydrophobic moment

Extracted from AAindex [148]: EISD860102

Direction of the hydrophobic moment

Extracted from AAindex [148]: EISD860103

B-values

Extracted from AAindex [148]: PARS000101

Distribution frequencies in thermophilic proteins

Extracted from AAindex [148]: KUMS000101

B-values for residues with a rigid neighbor

Extracted from AAindex [148]: VINM940103

14 A contact number

Extracted from AAindex [148]: NISK860101

Free energies of transfer peptides from bilayer interface to water

Extracted from AAindex [148]: WIMW960101

Optimized side chain interaction parameter

Extracted from AAindex [148]: OOBM850105

Fraction of site occupied by water

Extracted from AAindex [148]: KRIW790102

Partition coefficient for ionic strength

Extracted from AAindex [148]: ZASB820101

Side chain hydropathy corrected for solvation

Extracted from AAindex [148]: ROSM880102

Affinity to bind transmembrane regions

Extracted from AAindex [148]: NAKH900112

Solvation free energy

Extracted from AAindex [148]: EISD860101

Activation Gibbs energy of unfolding at pH 9.0

Extracted from AAindex [148]: YUTK870104

Relative preference value at N2

Extracted from AAindex [148]: RICJ880105

STERIMOL length of the side chain

Extracted from AAindex [148]: FAUJ880104

Transfer free energy from chx to oct

Extracted from AAindex [148]: RADA880104

Propensity for N-terminal turn

Extracted from AAindex [148]: ROBB760109

Side chain torsion angle

Extracted from AAindex [148]: LEVM760104

Ratio of average and computed composition

Extracted from AAindex [148]: NAKH900113

Helix initiation parameter

Extracted from AAindex [148]: FINA910101

Pleated-sheet propensity

Extracted from AAindex [148]: ROBB760106

AA composition of mt-proteins from fungi and plant

Extracted from AAindex [148]: NAKH900107

Alpha-helix propensity

Extracted from AAindex [148]: KOEP990101

Alpha-helix propensity for alpha/beta-proteins

Extracted from AAindex [148]: GEIM800104

Normalized alpha-helix frequency

Extracted from AAindex [148]: MAXF760101
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Supplementary Figure S1: ROC curves and AUC values on the test dataset for the prediction of DLBRs.
Solid lines represent results on the complete test dataset while dashed lines show results on the native
disordered residues in the test dataset.
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